成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

  • <rp id="ft4uq"></rp>
    <sup id="ft4uq"><i id="ft4uq"></i></sup><span id="ft4uq"><table id="ft4uq"><nobr id="ft4uq"></nobr></table></span>
    <samp id="ft4uq"><ins id="ft4uq"><em id="ft4uq"></em></ins></samp>
    <samp id="ft4uq"><dl id="ft4uq"><dl id="ft4uq"></dl></dl></samp>
  • Home Cart Sign in  
    Chemical Structure| 877399-52-5 Chemical Structure| 877399-52-5
    Chemical Structure| 877399-52-5

    *Storage: {[sel_prStorage]}

    *Shipping: {[sel_prShipping]}

    {[proInfo.proName]}

    CAS No.: 877399-52-5

    ,{[proInfo.pro_purity]}

    Crizotinib (PF-02341066) is an orally active ATP-competitive inhibitor of ALK and c-Met with IC50 values of 20 nM and 8 nM, respectively.

    Synonyms: PF-02341066; PF 2341066; (R)-Crizotinib

    4.5 *For Research Use Only !

    {[proInfo.pro_purity]}
    Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

    Change View

    Size Price VIP Price

    US Stock

    Global Stock

    In Stock
    {[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

    US Stock: ship in 0-1 business day
    Global Stock: ship in 2 weeks

    • {[ item.pr_size ]}

    In Stock

    - +

    Please Login or Create an Account to: See VIP prices and availability

    US Stock: ship in 0-1 business day
    Global Stock: ship in 2 weeks

    • 1-2 Day Shipping
    • High Quality
    • Technical Support Online Technical Q&A
    Product Citations

    Alternative Products

    Product Details of Crizotinib

    CAS No. :877399-52-5
    Formula : C21H22Cl2FN5O
    M.W : 450.34
    SMILES Code : NC1=NC=C(C2=CN(C3CCNCC3)N=C2)C=C1O[C@@H](C4=C(Cl)C=CC(F)=C4Cl)C
    Synonyms :
    PF-02341066; PF 2341066; (R)-Crizotinib
    MDL No. :MFCD12407409
    InChI Key :KTEIFNKAUNYNJU-GFCCVEGCSA-N
    Pubchem ID :11626560

    Safety of Crizotinib

    GHS Pictogram:
    Signal Word:Danger
    Hazard Statements:H317-H319-H341-H400
    Precautionary Statements:P273-P280-P305+P351+P338
    Class:9
    UN#:3077
    Packing Group:

    Related Pathways of Crizotinib

    RTK

    Isoform Comparison

    Biological Activity

    Target
    • ALK

      ROS1, Ki:<0.025 nM

      ALK, IC50:24 nM

    In Vitro:

    Cell Line
    Concentration Treated Time Description Reference
    RH4 cells 1.5 μM 72 h Inhibited cell proliferation and viability, induced apoptosis and autophagy PMC4596370
    H3122 cells 1 μM 6 months Generate crizotinib-resistant cell models PMC6895608
    RH30 cells 1.5 μM 72 h Inhibited cell proliferation and viability, induced apoptosis and autophagy PMC4596370
    HT29 1 μM 24 h To evaluate the effect of Crizotinib on autophagy, results showed that Crizotinib significantly induced autophagy. PMC6168336
    HCT116 1 μM 24 h To evaluate the effect of Crizotinib on autophagy, results showed that Crizotinib significantly induced autophagy. PMC6168336
    BM cells 20 μg/ml 16 h To analyze the effect of Crizotinib on HGF-induced phosphorylation of S6 and ERK, results showed that Crizotinib could prevent HGF-induced phosphorylation. PMC3645291
    SG16 cells 10 nM 72 h To evaluate the sensitivity of SG16 cells to Crizotinib, results showed that Crizotinib significantly impaired cell viability PMC6127885
    GTL16 cells 10 nM 72 h To evaluate the sensitivity of GTL16 cells to Crizotinib, results showed that Crizotinib significantly impaired cell viability PMC6127885
    EBC-1 cells 10 nM 72 h To evaluate the sensitivity of EBC-1 cells to Crizotinib, results showed that Crizotinib significantly impaired cell viability PMC6127885
    MCMs (mouse cardiomyocytes) 0.3125, 0.625, 1.25, 2.5, 5.0 μM 72 h To evaluate the effect of Crizotinib on cell survival, results showed that Crizotinib significantly reduced the survival fraction of MCMs. PMC10813574
    CCC-HEH-2 cells 0.3125, 0.625, 1.25, 2.5, 5.0 μM 72 h To evaluate the effect of Crizotinib on cell survival, results showed that Crizotinib significantly reduced the survival fraction of CCC-HEH-2 cells. PMC10813574
    RH30 cells 0.01 to 5 μM 72 h To evaluate the effect of Crizotinib on cell proliferation and viability, results showed that Crizotinib significantly inhibited the growth and viability of RH4 and RH30 cells in a dose-dependent manner PMC4596370
    RH4 cells 0.01 to 5 μM 72 h To evaluate the effect of Crizotinib on cell proliferation and viability, results showed that Crizotinib significantly inhibited the growth and viability of RH4 and RH30 cells in a dose-dependent manner PMC4596370
    ADK-VR2 AG143 1.5 μM 72 h To evaluate the inhibitory effect of Crizotinib on ADK-VR2 AG143 cells, results showed that the clone had significantly lower sensitivity to Crizotinib. PMC9742620
    ADK-VR2 0.5 μM 72 h To evaluate the inhibitory effect of Crizotinib on ADK-VR2 cells, results showed that Crizotinib partially inhibited cell growth. PMC9742620
    SK-N-BE(2)C 300 nM 6 h To study the effect of ALK inhibition on RET mRNA levels, results showed decreased RET mRNA levels PMC6168456
    CLB-MA 300 nM 6 h To study the effect of ALK inhibition on RET mRNA levels, results showed decreased RET mRNA levels PMC6168456
    CLB-GA 300 nM 6 h To study the effect of ALK inhibition on RET mRNA levels, results showed decreased RET mRNA levels PMC6168456

    In Vivo:

    Species
    Animal Model
    Administration Dosage Frequency Description Reference
    Nude mice Tumor xenograft model Oral 50 mg/kg Once daily, continuous treatment Evaluate the anti-tumor effect of crizotinib in tumor xenograft models PMC6895608
    NOD/SCID mice Subcutaneous tumor model Oral 25 mg/kg Once daily for 18 days To evaluate the anti-tumor effect of Crizotinib on GTL16 R-CRIZ cells in a mouse model, results showed that Crizotinib significantly inhibited tumor growth PMC6127885
    C57BL/6J mice Cardiac complications model Intragastric administration 100 mg/kg Once daily for 6 weeks To evaluate the effect of Crizotinib on cardiac function in mice, results showed that Crizotinib caused left ventricular dysfunction, myocardial injury, and pathological remodeling. PMC10813574
    NSG mice Immunodeficient mice Oral 50 mg/kg Daily, continuous treatment To evaluate the inhibitory effect of Crizotinib on ADK-VR2 tumor growth, results showed that Crizotinib significantly reduced tumor growth but did not completely eradicate the tumor. PMC9742620
    Mice MYCN/AlkF1178L neuroblastoma model Oral 100 mg/kg Daily treatment To study the effect of combining Crizotinib and Vandetanib on tumor growth, results showed the combination was more effective than Crizotinib alone PMC6168456
    Cynomolgus monkey Healthy cynomolgus monkey Intravenous injection 34.8 MBq/kg, 0.29 μg/kg Single injection, observed for 180 minutes To evaluate the distribution and elimination routes of [18F](R)-crizotinib in cynomolgus monkeys, showing low brain penetration (SUVmean = 0.1). PMC9782192

    Clinical Trial:

    NCT Number Conditions Phases Recruitment Completion Date Locations
    NCT02559778 Neuroblastoma Phase 2 Recruiting September 2026 -
    NCT03737994 ALK Gene Rearrangement ... More >> ALK Positive Non-Squamous Non-Small Cell Lung Carcinoma Stage IV Lung Cancer AJCC v8 Stage IVA Lung Cancer AJCC v8 Stage IVB Lung Cancer AJCC v8 Less << Phase 2 Not yet recruiting December 13, 2025 -
    NCT01871805 Non-Small Cell Lung Cancer Phase 1 Phase 2 Completed - -
    NCT03607188 Non-small Cell Lung Cancer Phase 1 Not yet recruiting January 31, 2020 -
    NCT02277457 Non-Small Cell Lung Cancer Early Phase 1 Withdrawn - United States, Michigan ... More >> University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48187 Less <<
    NCT01685060 Non-Small Cell Lung Cancer Phase 2 Completed - -
    NCT03574402 Carcinoma, Non-Small-Cell Lung Phase 2 Not yet recruiting December 30, 2024 -
    NCT02679170 Non-Small Cell Lung Cancer COMPLETED 2022-05-04 Hospital Clínico Univ. de Sant... More >>iago de Compostela, Santiago de Compostela, A Coru?a, 15076, Spain|Hospital Virgen de los Lirios, Alcoi, Alicante, 03804, Spain|Complejo Hospitalario de Jerez, Jerez de la Frontera, Cadiz, 11407, Spain|Hospital Marqués de Valdecilla, Santander, Cantabria, 9008, Spain|Hospital General Mancha Centro, Alcázar de San Juan, Ciudad REAL, 13600, Spain|Hospital Universitario de Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria, LAS Palmas, 35010, Spain|Hospital Universitario de Navarra, Pamplona, Navarra, 31008, Spain|Hospital Universitario Cruces, Barakaldo, Vizcaia, 48903, Spain|Hospital Universitario de Albacete, Albacete, 02006, Spain|Hospital Universitario Clinic i Provincial, Barcelona, 08036, Spain|Hospital Universitario de Burgos, Burgos, 09006, Spain|Hospital Universitario Puerta del Mar, Cádiz, Cadiz, 11009, Spain|Complejo Hospitalario de Jaen, Jaen, 23007, Spain|Complejo Hospitalario Universitario Insular Materno-Infantil, Las Palmas de Gran Canaria, 35016, Spain|Hospital Universitario de León, León, 24080, Spain|Hospital Universitario San Pedro, Logro?o, Logro?o, 26006, Spain|Hospital Universitario Lucus Augusti (HULA_ Lugo), Lugo, 27003, Spain|Hospital Universitario de La Princesa, Madrid, 28006, Spain|Hospital Universitario Gregorio Mara?ón, Madrid, 28007, Spain|Hospital Universitario Clinico San Carlos, Madrid, 28040, Spain|Hospital Universitario Fundación Jimenez Diaz, Madrid, 28040, Spain|H.U. La Paz, Madrid, 28046, Spain|Hospital Regional Universitario Carlos Haya, Malaga, 29010, Spain|Hospital Universitario Arrixaca, Murcia, 30120, Spain|Complejo Hospitalario Universitario de Ourense (CHUOU), Orense, 32005, Spain|Hospital Universitario Central de Asturias, Oviedo, 33011, Spain|HU Son Llatzer, Palma de Mallorca / Servicio de Oncología Médica, Palma de Mallorca, 07198, Spain|Hospital Universitario de la Candelaria, Tenerife, Santa Cruz de Tenerife, 38010, Spain|Hospital Universitario Virgen Macarena, Sevilla, 41009, Spain|Hospital Virgen de La Salud, Toledo, 45004, Spain|Hospital Universitario y Politecnico La Fe, Valencia, 46026, Spain|Hospital Universitario de Vigo- Hospital álvaro Cunqueiro / Servicio de Oncología Médica, Vigo, 36312, Spain Less <<
    NCT01822496 Stage III Non-Small Cell Lung ... More >>Cancer AJCC v7 Stage IIIA Non-Small Cell Lung Cancer AJCC v7 Stage IIIB Non-Small Cell Lung Cancer AJCC v7 Less << Phase 2 Terminated - -
    NCT02040870 Non-Small Cell Lung Cancer Phase 1 Phase 2 Completed - China, Beijing ... More >> Novartis Investigative Site Beijing, Beijing, China, 100730 China, Chongqing Novartis Investigative Site Chongqing, Chongqing, China, 400037 China, Guangdong Novartis Investigative Site Guangzhou, Guangdong, China, 51000 China, Jilin Novartis Investigative Site Changchun, Jilin, China, 130012 China, Shanghai Novartis Investigative Site Shanghai, Shanghai, China, 200032 Novartis Investigative Site Shanghai, Shanghai, China, 200433 China, Shanxi Novartis Investigative Site Xi'an, Shanxi, China, 710038 China, Sichuan Novartis Investigative Site Chengdu, Sichuan, China, 610041 China, Zhejiang Novartis Investigative Site Hangzhou, Zhejiang, China, 310003 China Novartis Investigative Site Beijing, China, 100021 Novartis Investigative Site Beijing, China, 100036 Novartis Investigative Site Beijing, China, 100039 Novartis Investigative Site Chongqing, China, 400038 Novartis Investigative Site Guang Dong Province, China, 510120 Novartis Investigative Site Guangzhou, China, 510060 Less <<
    NCT01685060 - Completed - -
    NCT01685138 Non-Small Cell Lung Cancer Phase 2 Completed - -
    NCT02604342 - Completed - -
    NCT01801111 Non-Small-Cell Lung Carcinoma Phase 1 Phase 2 Completed - -
    NCT01828112 Non-Small Cell Lung Cancer Phase 3 Active, not recruiting February 15, 2021 -
    NCT01871805 - Completed - -
    NCT02604342 Non-small Cell Lung Cancer Phase 3 Completed - -
    NCT01801111 - Completed - -
    NCT01828112 - Active, not recruiting - -
    NCT01637597 - Unknown March 2017 Taiwan ... More >> Department of Oncology, National Taiwan University Hospital Taipei, Taiwan, 100 Less <<
    NCT01970865 ALK-positive Non Small Cell Lu... More >>ng Cancer (NSCLC) and ROS1-positive NSCLC Less << Phase 2 Active, not recruiting February 19, 2019 -
    NCT00585195 Non-Small Cell Lung Cancer ALK... More >>-positive Non-Small Cell Lung Cancer c-Met Dependent Non-Small Cell Lung Cancer ROS Marker Positive Systemic Anaplastic Large-Cell Lymphoma Advanced Malignancies Except Leukemia Less << Phase 1 Recruiting July 14, 2023 -
    NCT03596866 ALK-positive Advanced NSCLC Phase 3 Not yet recruiting September 4, 2023 -
    NCT02228421 - Active, not recruiting - Canada, Ontario ... More >> The Ottawa Hospital Ottawa, Ontario, Canada, K1H 8L6 Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec CSSS de Rimouski-Neigette Rimouski, Quebec, Canada, J5L 5T1 Less <<
    NCT03215693 Non-Small Cell Lung Cancer Phase 2 Recruiting December 2018 China ... More >> Beijing Cancer Hospital Recruiting Beijing, China Contact: Jian Fang, MD ?? 13701224460 ?? fangjian5555@163.com ?? Principal Investigator: Jun Zhao, MD ?? ?? ?? Beijing Chest Hospital,Capital Medical University Recruiting Beijing, China Contact: Shucai Zhang, MD ?? 13901297065 ?? sczhang6304@163.com ?? Department of Medical Oncology, Cancer Institute/Hospital, Chinese Academy of Medical Sciences Recruiting Beijing, China Contact: Junling Li, MD ?? 13801178891 ?? drlijunling@vip.163.com ?? Peking Union College Hospital Recruiting Beijing, China Contact: Wei Zhong, MD ?? 13810616395 ?? zw_pumch@126.com Less <<
    NCT03718117 - Recruiting December 6, 2019 France ... More >> Centre Hospitalier Intercommunal du Pays d'Aix-Pertuis,Service de Pneumologie Recruiting Aix en Provence, France, 13616 Clinique de l Europe Recruiting Amiens, France, 80000 Centre Hospitalier d Avignon Recruiting Avignon, France, 84902 Centre Hospitalier de Beauvais Recruiting Beauvais, France, 60021 Centre Hospitalier General Beziers, Service De Pneumologie Recruiting Beziers, France, 34525 Centre Hospitalier de Cannes Recruiting Cannes, France, 06414 Centre Hospitalier Chalon sur Saone William Morey Recruiting Chalon sur Saone, France, 71321 Centre Hospitalier Metropole de Savoie-Site de Chambery Recruiting Chambery, France, 73000 Hopitaux Civils de Colmar - Hopital Louis Pasteur Recruiting Colmar Cedex, France, 68024 Centre Hospitalier Alpes Leman Recruiting Contamine sur Arve, France, 74130 Centre Hospitalier Intercommunal Frejus Recruiting Frejus, France, 83600 Centre Hospitalier Départemental Les Oudairies Recruiting La Roche Sur Yon Cedex 9, France, 85925 CHD Vendee Recruiting La Roche Sur Yon, France, 85925 Le Mans Hospital Center Recruiting Le Mans, France, 72037 Centre Hospitalier De Libourne - Hopital Robert Boulin Recruiting Libourne, France, 33505 Centre Hospitalier des Deux Vallees - Longjumeau BP 125 Recruiting Longjumeau, France, 91161 Centre Hospitalier de Macon Recruiting Macon cedex, France, 71018 Hopital Europeen - Service de Pneumologie Recruiting Marseille, France, 13003 GHR Mulhouse Sud Alsace Recruiting Mulhouse, France, 68051 Centre Hospitalier Regional d Orleans Recruiting Orleans, France, 45000 Centre Hospitalier Annecy Genevois Recruiting Pringy, France, 74374 Groupe Hospitalier Sud Reunion Recruiting Saint Pierre La Réunion, France, 97448 Hopitaux du Leman Recruiting Thonon les Bains, France Centre Hospitalier de Troyes, Service de Pneumologie - Oncologie Thoracique Recruiting Troyes, France, 10003 Centre Hospitalier de Villefranche sur Saone - BP80436 Recruiting Villefranche sur Saone, France, 69655 Less <<
    NCT02094573 Carcinoma, Non-Small-Cell Lung Phase 2 Active, not recruiting September 21, 2020 -
    NCT01154140 Non Squamous Lung Cancer Phase 3 Completed - -
    NCT01154140 - Completed - -
    NCT00939731 - Completed - -
    NCT02006277 Healthy Phase 1 Completed - Belgium ... More >> Pfizer Investigational Site Brussels, Belgium, B-1070 Less <<
    NCT00939731 Healthy Phase 1 Completed - United States, Connecticut ... More >> Pfizer Investigational Site New Haven, Connecticut, United States, 06511 Less <<
    NCT01970865 - Active, not recruiting - -
    NCT02094573 - Active, not recruiting - -
    NCT02510001 Solid Tumor C... More >>olorectal Cancer Less << Phase 1 Active, not recruiting September 2019 United Kingdom ... More >> Oxford University Hospital NHS Trust Oxford, United Kingdom, OX3 7LE Less <<
    NCT02708667 - Unknown May 2016 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510000 Contact: Likun Chen, doctor ?? 13798019964 Less <<
    NCT01300429 - Active, not recruiting February 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
    NCT03194893 Neoplasms Phase 3 Recruiting June 12, 2024 -
    NCT01441388 Carcinoma, Renal Cell ... More >> Glioblastoma Carcinoma, Hepatocellular Less << Phase 1 Withdrawn(Business/Operational... More >> issues) Less << November 2013 -
    NCT01441128 Carcinoma, Non-Small Cell Lung... More >> Adenocarcinoma Carcinoma, Squamous Cell Carcinoma, Large Cell Less << Phase 1 Terminated - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
    NCT01121575 Non Small Cell Lung Cancer Phase 1 Completed - United States, Colorado ... More >> Clinical Trials Office University of Colorado Hospital (CTO) Aurora, Colorado, United States, 80045 DRUG SHIPMENT: University of Colorado Cancer Center Aurora, Colorado, United States, 80045 Rocky Mountain Lions Eye Institute Aurora, Colorado, United States, 80045 University of Colorado Hospital Aurora, Colorado, United States, 80045 United States, Maryland CCR, National Cancer Institute Bethesda, Maryland, United States, 20892 United States, Massachusetts Drug Shipment Only Boston, Massachusetts, United States, 02114 Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Brigham & Women's Hospital Boston, Massachusetts, United States, 02115 Drug Shipment Only Boston, Massachusetts, United States, 02215 Australia, Victoria Peter MacCallum Cancer Centre, Division of Haematology and Medical Oncology East Melbourne, Victoria, Australia, 3002 Less <<
    NCT01121575 - Completed - -
    NCT01979536 Anaplastic Large Cell Lymphoma... More >>, ALK-Positive Ann Arbor Stage II Noncutaneous Childhood Anaplastic Large Cell Lymphoma Ann Arbor Stage III Noncutaneous Childhood Anaplastic Large Cell Lymphoma Ann Arbor Stage IV Noncutaneous Childhood Anaplastic Large Cell Lymphoma CD30-Positive Neoplastic Cells Present Less << Phase 2 Recruiting December 31, 2021 -
    NCT02041468 - Active, not recruiting June 2018 Canada, Ontario ... More >> Ottawa Hospital Ottawa, Ontario, Canada, K1H 8L6 Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec McGill University Health Center (JGH, St-Mary's, MGH, RVH) Montreal, Quebec, Canada, H3T 1E2 Centre hospitalier de l'Université de Montréal Montreal, Quebec, Canada H?pital du Sacré-Coeur de Montréal Montréal, Quebec, Canada, H4J 1C5 CSSS Rimouski Rimouski, Quebec, Canada, G5L 5T1 Centre Hospitalier Universitaire de Sherbrooke Sherbrooke, Quebec, Canada, J1H 5N4 Canada Institut Universitaire de cardiologie et de pneumonologie Quebec, Canada, G1V 4G5 Less <<
    NCT00932893 Carcinoma, Non-Small-Cell Lung Phase 3 Completed - -
    NCT01999972 Advanced Solid Tumors Phase 1 Active, not recruiting July 31, 2018 United States, Illinois ... More >> University of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, Indiana Investigational Drug Services IUHSCC Indianapolis, Indiana, United States, 46202 IU Health University Hospital Indianapolis, Indiana, United States, 46202 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Michigan Wayne State University, Dept. of Oncology Detroit, Michigan, United States, 48201 United States, Minnesota University of Minnesota Health Clinics and Surgery Center Minneapolis, Minnesota, United States, 55455 University of Minnesota Medical Center, Fairview IDS Pharmacy Minneapolis, Minnesota, United States, 55455 University of Minnesota Medical Center, Fairview Minneapolis, Minnesota, United States, 55455 University of Minnesota Physicians Masonic Cancer Center Minneapolis, Minnesota, United States, 55455 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, Utah Huntsman Cancer Hospital Salt Lake City, Utah, United States, 84112 Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 John A Moran Eye Center Salt Lake City, Utah, United States, 84132 United States, Wisconsin University Station Ophthalmology Clinic Madison, Wisconsin, United States, 53705 University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 United Kingdom St Bartholomew's Hospital - Barts Health NHS Trust London, United Kingdom, EC1A 7BE The Royal Marsden NHS Foundation Trust, Royal Marsden Hospital London, United Kingdom, SW3 6JJ Less <<
    NCT01250730 Healthy Phase 1 Completed - Japan ... More >> Pfizer Investigational Site Hachioji-shi, Tokyo, Japan Less <<
    NCT00965731 Non-Small Cell Lung Cancer Phase 1 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35233 University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, California University of California, Irvine Medical Center Pharmacy Orange, California, United States, 92868-3298 University of California, Irving - Medical Center Orange, California, United States, 92868-3298 University of California Irvin Orange, California, United States, 92868 United States, Florida Holy Cross Hospital Fort Lauderdale, Florida, United States, 33308 United States, Missouri Siteman Cancer Center -West County Creve Coeur, Missouri, United States, 63141 Barnes-Jewish Hospital St. Louis, Missouri, United States, 63110-1094 Washington University, School of Medicine St. Louis, Missouri, United States, 63110 Siteman Cancer Center St. Peters, Missouri, United States, 63376 United States, Ohio OSU East Columbus, Ohio, United States, 43205 The Ohio State University James Cancer Hospital Columbus, Ohio, United States, 43210 James Care in Kenny Columbus, Ohio, United States, 43221 United States, Texas Cancer Therapy & Research Center @ UTHSCSA San Antonio, Texas, United States, 78229 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 University of Washington Medical Center Seattle, Washington, United States, 98195 Less <<
    NCT01250730 - Completed - -
    NCT02761057 Stage III Renal Cell Cancer AJ... More >>CC v7 Stage IV Renal Cell Cancer AJCC v7 Type 1 Papillary Renal Cell Carcinoma Type 2 Papillary Renal Cell Carcinoma Unresectable Renal Cell Carcinoma Less << Phase 2 Suspended(Scheduled Interim Mo... More >>nitoring) Less << - -
    NCT03126916 Childhood Ganglioneuroblastoma... More >> Childhood Neuroblastoma INRG Stage L2 INRG Stage M INRG Stage MS NMYC Gene Amplification Recurrent Neuroblastoma Less << Phase 3 Recruiting June 30, 2026 -
    NCT02584634 Non-Small Cell Lung Cancer Phase 2 Active, not recruiting March 20, 2020 United States, Georgia ... More >> Emory University Hospital Midtown Atlanta, Georgia, United States, 30308 Emory Investigational Drug Service Atlanta, Georgia, United States, 30322 Emory University Hospital Atlanta, Georgia, United States, 30322 The Emory Clinic Atlanta, Georgia, United States, 30322 Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114-2696 Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Ophthalmic Consultants of Boston Inc (OCB) Boston, Massachusetts, United States, 02114 United States, Tennessee Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37203 The Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 Australia, New South Wales Chris O'Brien Lifehouse Camperdown, New South Wales, Australia, 2050 Australia, Queensland The Prince Charles Hospital Chermside, Queensland, Australia, 4032 Australia, Victoria Peter MacCallum Cancer Centre Melbourne, Victoria, Australia, 3000 Royal Melbourne Hospital Parkville, Victoria, Australia, 3050 Japan Aichi cancer center central hospital Nagoya, Aichi, Japan, 464-8681 National Hospital Organization Kyushu Cancer Center Fukuoka, Japan, 811-1395 The Cancer Institute Hospital of JFCR Koto-ku, Tokyo, Japan, 135-8550 Korea, Republic of National Cancer Center Goyang-Si, Gyeonggi-do, Korea, Republic of, 10408 Asan Medical Center Seoul, Korea, Republic of, 05505 Clinical Research Pharmacy, Asan Medical Center Seoul, Korea, Republic of, 05505 Samsung Medical Center Seoul, Korea, Republic of, 06351 Spain Institut Catala d'Oncologia de Badalona,Unidad de Farmacia Oncologica-Ensayos Clinicos Badalona, Barcelona, Spain, 08916 Institut Catala d'Oncologia de Badalona Badalona, Barcelona, Spain, 08916 Hospital Quiron Barcelona Barcelona, Spain, 08023 Hospital Universitari de la Vall d'Hebron Barcelona, Spain, 08035 Less <<
    NCT00932893 - Completed - -
    NCT00932451 Carcinoma, Non-Small-Cell Lung PHASE2 COMPLETED 2025-12-15 University of Alabama at Birmi... More >>ngham, Birmingham, Alabama, 35233, United States|University of Alabama at Birmingham, Birmingham, Alabama, 35294, United States|University of Arkansas for Medical Sciences, Little Rock, Arkansas, 72205, United States|Comprehensive Blood and Cancer Center, Bakersfield, California, 93309, United States|Tower Cancer Research Foundation, Beverly Hills, California, 90211-1850, United States|Tower Hematology Oncology Medical Group, Beverly Hills, California, 90211-1850, United States|Moores UCSD Cancer Center, La Jolla, California, 92037, United States|UCSD Medical Center - La Jolla, La Jolla, California, 92093-0698, United States|Drug Shipping Address: Ronald Reagen University of California-Los Angeles, Los Angeles, California, 90095-6984, United States|Ronald Reagen University of California-Los Angeles Medical Center, Los Angeles, California, 90095, United States|UCLA Opthalmic Oncology Center, Los Angeles, California, 90095, United States|University of California-Los Angeles, Los Angeles, California, 90095, United States|University of California, Irvine-Medical Center, Orange, California, 92868-3298, United States|University of California, Irvine-Pharmacy, Orange, California, 92868-3298, United States|Stanford University-Cancer Center, Palo Alto, California, 94305, United States|UC Davis Cancer Center, Sacramento, California, 95817, United States|University of California Davis Medical Center, Sacramento, California, 95817, United States|UCSD Medical Center - Hillcrest, San Diego, California, 92103, United States|Santa Monica-UCLA Medical Center & Orthopaedic Hospital Clinical Laboratory, Santa Monica, California, 90404, United States|UCLA Hematology Oncology-Santa Monica, Santa Monica, California, 90404, United States|University of California-Los Angeles, Santa Monica, California, 90404, United States|Redwood Regional Medical Group Inc, Santa Rosa, California, 95403, United States|DRUG SHIPMENT: University of Colorado Cancer Center, Aurora, Colorado, 80045, United States|Rocky Mountain Lions Eye Institute, Aurora, Colorado, 80045, United States|University of Colorado Hospital, Aurora, Colorado, 80045, United States|Kaiser Permanente Colorado - Franklin, Denver, Colorado, 80205, United States|Kaiser Permanente Colorado - Rock Creek, Lafayette, Colorado, 80026, United States|Smilow Cancer Center at Yale New Haven, Oncology Pharmacy, New Haven, Connecticut, 06510, United States|Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut, 06510, United States|Yale University, New Haven, Connecticut, 06520, United States|Michael and Dianne Bienes Cancer Center, Holy Cross Hospital, Fort Lauderdale, Florida, 33308, United States|Memorial Cancer Institute, Hollywood, Florida, 33021, United States|Cancer Center of South Florida Foundation, Inc., Lake Worth, Florida, 33461, United States|Memorial Cancer Center (West), Pembroke Pines, Florida, 33028, United States|H Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, 33612, United States|Emory University Hospital Midtown, Atlanta, Georgia, 30308, United States|Emory Clinic, Atlanta, Georgia, 30322, United States|Emory University Clinic, Atlanta, Georgia, 30322, United States|Emory University Hospital, Atlanta, Georgia, 30322, United States|Winship Cancer Institution, Atlanta, Georgia, 30322, United States|Georgia Cancer Specialists - Administrative Annex, Atlanta, Georgia, 30341, United States|MCG Health Cancer Center Pharmacy, Augusta, Georgia, 30912, United States|MCG Health System Pharmacy (Drug Shipment Only), Augusta, Georgia, 30912, United States|Medical College of Georgia, Augusta, Georgia, 30912, United States|Georgia Cancer Specialists-Stemmer, Decatur, Georgia, 30033, United States|Georgia Cancer Specialists-Macon, Macon, Georgia, 31217, United States|Georgia Cancer Specialists-Kennestone, Marietta, Georgia, 30060, United States|Georgia Cancer Specialists-Northside, Sandy Springs, Georgia, 30342, United States|OnCare Hawaii, Inc., Honolulu, Hawaii, 96813, United States|University of Hawaii - Cancer Research Center of Hawaii, Honolulu, Hawaii, 96813, United States|Hawaii Medical Center East, Honolulu, Hawaii, 96817, United States|Rush University Medical Center, Chicago, Illinois, 60612, United States|University of Chicago Medical Center (Attn: J Pi PharmD / A. Patel Pharm D), Chicago, Illinois, 60637, United States|University of Chicago Medical Center, Chicago, Illinois, 60637, United States|Ingalls Memorial Hospital (Drug Shipment Only), Harvey, Illinois, 60426, United States|Ingalls Memorial Hospital, Harvey, Illinois, 60426, United States|Monroe Medical Associates, Harvey, Illinois, 60426, United States|Monroe Medical Associates, Tinley Park, Illinois, 60477, United States|Indiana University Hospital Clarian Health, Indianapolis, Indiana, 46202, United States|Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, 46202, United States|Ship drug to: Investigational Drug Services, Indianapolis, Indiana, 46202, United States|Wishard Memorial Hospital, Indianapolis, Indiana, 46202, United States|Springmill Medical Clinic, Indianopolis, Indiana, 46290, United States|Monroe Medical Associates, Munster, Indiana, 46321, United States|The Community Hospital, Munster, Indiana, 46321, United States|Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, 21231, United States|The Harry and Jeanette Cancer Research Building, Baltimore, Maryland, 21231, United States|National Institutes of Health National Cancer Institute, Bethesda, Maryland, 20892, United States|Massachusette General Hospital, Boston, Massachusetts, 02114, United States|Massachussetts General Hospital, Boston, Massachusetts, 02114, United States|Beth Isreal Deaconess Medical Center, Pharmacy FD B18, Boston, Massachusetts, 02115, United States|Brigham and Women's Hospital, Boston, Massachusetts, 02115, United States|Beth Isreal Deaconess Medical Center, Boston, Massachusetts, 02215, United States|Dana Farber Cancer Institute/Pharmacy, Boston, Massachusetts, 02215, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Karmanos Cancer Institute, Detroit, Michigan, 48201, United States|Karmanos Cancer lnstitute at Farmington Hllls, Farmington Hills, Michigan, 48334, United States|Barnes-Jewish Hospital, St. Louis, Missouri, 63110-1094, United States|Washington University School of Medicine, St. Louis, Missouri, 63110, United States|Siteman Cancer Center, St. Peters, Missouri, 63376, United States|University of Nebraska Medical Center, Omaha, Nebraska, 68198-7680, United States|Dartmouth Hitchcock Medical Center/Mary Hitchcock Memorial Hospital, Lebanon, New Hampshire, 03756-0001, United States|University of New Mexico Eye Clinic, Albuquerque, New Mexico, 87106, United States|University of New Mexico Cancer Center, Albuquerque, New Mexico, 87131, United States|NSLIJ Health System/Monter Cancer Center, Lake Success, New York, 11042, United States|North Shore University Hospital, Manhasset, New York, 11030, United States|Long Island Jewish Medical Center, New Hyde Park, New York, 11040, United States|Memorial Sloan-Kettering Cancer Center: Rockefeller Outpatient Pavilion, New York, New York, 10022, United States|Columbia University Medical Center, New York, New York, 10032, United States|IP Shipment: CUMC Research Pharmacy, New York, New York, 10032, United States|Memorial Sloan - Kettering Cancer Center, New York, New York, 10065, United States|Department of Medicine MSG at SUNY HSC at Syracuse, INC., d/b/a University Physicians, Oneida, New York, 13421, United States|Department of Medicine MSG at SUNY HSC at Syracuse, INC., d/b/a University Physicians, Oswego, New York, 13126, United States|SUNY Upstate Medical University, Regional Oncology Center, Syracuse, New York, 13210-2306, United States|Department of Medicine MSG at SUNY HSC at Syracuse, INC., d/b/a University Physicians, Syracuse, New York, 13210, United States|UNC Health Care, Chapel Hill, North Carolina, 27514, United States|UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599-7600, United States|Presbyterian Hospital Cancer Center, Charlotte, North Carolina, 28204, United States|Presbyterian Hospital Huntersville, Huntersville, North Carolina, 28078, United States|Southern Oncology Specialists, Huntersville, North Carolina, 28078, United States|Presbyterian Hospital Matthews, Matthews, North Carolina, 28105, United States|Cleveland Clinic, Cleveland, Ohio, 44195, United States|The Ohio State University Hospital East, Columbus, Ohio, 43205, United States|The Ohio State University Investigational Drug Services, Columbus, Ohio, 43210, United States|The Ohio State University James Cancer Hospital and Solove Research Institute, Columbus, Ohio, 43210, United States|James Care in Kenny, Columbus, Ohio, 43221, United States|Oregon Health and Science University, Portland, Oregon, 97239, United States|Penn State Milton S. Hershey Medical Center, Penn State Hershey Cancer Institute, Hershey, Pennsylvania, 17033-0850, United States|Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States|Penn Presbyterian Medical Center, Philadelphia, Pennsylvania, 19104, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, 19111, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, 15232, United States|Vincent Armenio, MD, East Providence, Rhode Island, 02914, United States|Pharma Resource, East Providence, Rhode Island, 02915, United States|Medical University of South Carolina - Hollings Cancer Center, Charleston, South Carolina, 29425, United States|Tennessee Oncology, PLLC, Dickson, Tennessee, 37055, United States|Tennessee Oncology, PLLC, Franklin, Tennessee, 37067, United States|Tennessee Oncology, PLLC, Gallatin, Tennessee, 37066, United States|Tennessee Oncology, PLLC, Hermitage, Tennessee, 37076, United States|Tennessee Oncology, PLLC, Lebanon, Tennessee, 37087, United States|Tennessee Oncology, PLLC, Murfreesboro, Tennessee, 37130, United States|Sarah Cannon Research Institute (Administration), Nashville, Tennessee, 37203, United States|Sarah Cannon Research Institute (Pharmacy), Nashville, Tennessee, 37203, United States|Tennessee Oncology, PLLC, Nashville, Tennessee, 37203, United States|Tennessee Oncology, PLLC, Nashville, Tennessee, 37205, United States|Tennessee Oncology, PLLC, Nashville, Tennessee, 37207, United States|Tennessee Oncology, PLLC, Nashville, Tennessee, 37211, United States|Vanderbilt Cancer Clinic, Nashville, Tennessee, 37232-5536, United States|The Vanderbilt Chemo Clinic, Nashville, Tennessee, 37232-7610, United States|Tennessee Oncology, PLLC, Smyrna, Tennessee, 37167, United States|UT Southwestern Medical Center - Simmons Cancer Center Pharmacy, Dallas, Texas, 75390-9015, United States|University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, 75390, United States|University of Texas Southwestern University Hospital - Zale Lipshy, Dallas, Texas, 75390, United States|UT Southwestern University Hospital - William P. Clements, Jr, Dallas, Texas, 75390, United States|The University of Texas, Houston, Texas, 77030, United States|Swedish Cancer Institute, Seattle, Washington, 98104, United States|Seattle Cancer Care Alliance, Seattle, Washington, 98109, United States|Lisa Nakatsu, RPh (Drug Shipment Address), Seattle, Washington, 98122, United States|Swedish Medical Center, Seattle, Washington, 98122, United States|University of Washington Medical Center, Seattle, Washington, 98195, United States|Chris O'Brien Lifehouse, Camperdown, New South Wales, 2050, Australia|Royal Adelaide Hospital, Department of Medical Oncology, Adelaide, South Australia, 5000, Australia|Peter MacCallum Cancer Centre, Division of Haematology and Medical Oncology, East Melbourne, Victoria, 3002, Australia|Department of Medical Oncology, Nedlands, Western Australia, 6009, Australia|Nucleo de Oncologia da Bahia, Salvador, Bahia, 40170-110, Brazil|Instituto Nacional do Cancer - INCA, Rio de Janeiro, RJ, 20231-050, Brazil|Associacao Hospital de Caridade de Ijui, Ijui, RS, 98700-000, Brazil|Irmandade da Santa Casa de Misericordia de Porto Alegre, Porto Alegre, RS, 90050-170, Brazil|Hospital Sao Lucas da PUCRS, Porto Alegre, RS, 90610-000, Brazil|Fundacao Hospital Amaral Carvalho, Jau, Sao Paulo, 17210-120, Brazil|Fundacao Pio XII Hospital de Cancer de Barretos, Barretos, SP, 14784-400, Brazil|Instituto do Cancer do Estado de S?o Paulo Octavio Frias de Oliveira - ICESP, Sao Paulo, SP, 01246-000, Brazil|Fundacao Antonio Prudente, Sao Paulo, SP, 01509-900, Brazil|UMHAT Tsaritsa Yoanna - ISUL, Sofia, 1527, Bulgaria|MBAL Voennomeditsinska Academia, MMA HAT Sofia, Sofia, 1606, Bulgaria|Spetsializirana Bolnitsa za Aktivno Lechenie po Onkologiya, Klinika po himioterapiya, Sofia, 1756, Bulgaria|MDOZS "Dr. Marko Markov", Otdelenie po onkoterapiya i paliativni grizhi, Varna, 9002, Bulgaria|Tom Baker Cancer Centre, Calgary, Alberta, T2N 4N2, Canada|Alberta Health Services, Holy Cross Site, Calgary, Alberta, T2S 3C3, Canada|Office of Dr. John McWhae, Calgary, Alberta, T2V 2C4, Canada|Cross Cancer Institute, Edmonton, Alberta, T6G 1Z2, Canada|Dr. Georges-L. Dumont Regional Hospital, Moncton, New Brunswick, E1C 2Z3, Canada|Dr. Leon Richard Oncology Centre, Moncton, New Brunswick, E1C 8X3, Canada|RSM Durham Regional Cancer Centre - Lakeridge Health Oshawa, Oshawa, Ontario, L1G 2B9, Canada|Dr. Dana Blakolmer and Associates, Oshawa, Ontario, L1J 8N8, Canada|The Ottawa Hospital Cancer Center, Ottawa, Ontario, K1H 8L6, Canada|Hopital Notre-Dame du Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal, Quebec, H2L 4M1, Canada|Royal Victoria Hospital, Montreal, Quebec, H3A 1A1, Canada|Montreal General Hospital, Montreal, Quebec, H3G 1A4, Canada|Jewish General Hospsital, Montreal, Quebec, H3T 1E2, Canada|St. Mary's Hospital Center, Montreal, Quebec, H3T 1M5, Canada|SUN Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, China|Nanjing Bayi Hospital, Nanjing, Jiangsu, 210002, China|Cancer Institute and Hospital Chinese Academy of Medical Sciences and PUMC, Internal 4 Department, Beijing, 100021, China|307 Hospital of PLA, Beijing, 100071, China|Guangdong General Hospital, Guangzhou, 510080, China|Shanghai Chest Hospital/Department of Pulmonary Medicine, Shanghai, 200030, China|Shanghai Chest Hospital, Shanghai, 200030, China|Zhongshan Hospital Fudan University / Respiratory Department, Shanghai, 200032, China|Shanghai Pulmonary Hospital, Shanghai, 200433, China|Centre Francois Baclesse, Caen Cedex 05, 14076, France|Centre Georges-Fran?ois Leclerc, Dijon, 21079, France|Hopital Albert Michallon, Grenoble Cedex 09, 38043, France|APHM - Hopital Nord / Service d'Oncologie Multidisciplinaire et Innovations Thérapeutiques, Marseille Cedex 20, 13915, France|Centre Antoine Lacassagne, NICE Cedex 2, 06189, France|Hopital Tenon, Paris cedex 20, 75970, France|Hospital Cochin, Paris, 75014, France|Centre Rene Gauducheau / Service d'Oncologie Medicale, St Herblain Cedex, 44805, France|Institut Gustave Roussy, Villejuif, 94805, France|Universitaetsklinikum Carl-Gustav-Carus Dresden, Dresden, 01307, Germany|Westdeutsches Tumorzentrum, Universitaetsklinikum Essen, Innere Klinik - Tumorforschung, Essen, 45122, Germany|Krankenhaus Grosshansdorf, Zentrum fuer Pneumologie und Thoraxchirurgie, Grosshansdorf, 22927, Germany|Ambulantes Krebszentrum Hamburg, Hamburg, 22527, Germany|Thoraxklinik Heidelberg gGmbH, Heidelberg, 69126, Germany|Klinikum der Universitaet zu Koeln, Klinik I fuer Innere Medizin, Koeln, 50937, Germany|Klinikum der Universitaet Muenchen, Medizinische Klink - Innenstadt, Pneumologie, Muenchen, 80336, Germany|Pius-Hospital Oldenburg, Oldenburg, 26121, Germany|HSK Dr.- Horst-Schmidt-Kliniken, Wiesbaden, 65199, Germany|University General Hospital of Heraklion/ Department of Clinical Oncology, Heraklion, Crete, 71110, Greece|General Hospital of Thessaloniki Georgios Papanikolaou, Lung Cancer Neoplasia Research Department, Exohi, Thessaloniki, 57010, Greece|General Hospital of Chest Diseases of Athens "Sotiria", Athens, 11527, Greece|Division of Respiratory and Critical Care Medicine, Department of Medicine, Queen Mary Hospital, Pokfulam, Hong Kong|Department of Clinical Oncology, Prince of Wales Hospital, Shatin, New Territories, Hong Kong|Tuen Mun Hospital, Department of Clinical Oncology, Tuen Mun, New Territories, Hong Kong|Orszagos Koranyi TBC es Pulmonologiai Intezet, VI. Bronchologia, Budapest, 1121, Hungary|Semmelweis Egyetem Pulmonologia Intezet, Budapest, 1125, Hungary|Debreceni Egyetem Orvos - es Egeszsegtudomanyi Centrum, Tudogyogyaszati Klinika, Debrecen, 4032, Hungary|Veszprem Megyei Onkormanyzat Tudogyogyintezete, Farkasgyepu, 8582, Hungary|Fejer Megyei Szent Gyorgy Korhaz, Pulmonologiai Osztaly, Szekesfehervar, 8000, Hungary|Pest Megyei Tudogyogyintezet, III. Osztaly, Torokbalint, 2045, Hungary|Aseptic Compounding Unit, Dublin, 8, Ireland|Department of Medical Oncology, Dublin, Dublin 8, Ireland|Department of Medical Oncology, Galway, Ireland|Merlin Park Imaging Centre, Galway, Ireland|Pharmacy Aseptic Services Unit, Galway, Ireland|Divisione di Oncologia Medica, Ospedale San Giuseppe Moscati, Citta' Ospedaliera, Avellino, 83100, Italy|S.C. Oncologia Medica, Firenze, 50134, Italy|Oncologia Medica A, Genova, 16132, Italy|Ospedale Versilia, Oncologia Medica, Lido di Camaiore (LU), 55043, Italy|Ospedale San Luca, Lucca, 55100, Italy|Dipartimento Oncologia Medica, UO Medicina 1Q A, Unita' Nuovi Farmaci e Terapie Innovative, Milano, 20132, Italy|Farmacia Istituto Europeo di Oncologia, Milano, 20141, Italy|Istituto Europeo di Oncologia, Milano, 20141, Italy|Ospedale Niguarda Ca' Granda Dipartimento Oncologico, SC Divisione di Oncologia Medica Falk, Milano, 20162, Italy|Nuovo Ospedale San Gerardo, Monza, 20900, Italy|Azienda Ospedaliera Universitaria San Luigi Gonzaga, Orbassano (TO), 10043, Italy|SC Oncologia Medica, Ospedale Santa Maria della Misericordia, Azienda Ospedaliera di Perugia, Perugia, 06156, Italy|Unita' Operativa Complessa di Pneumologia Oncologica I, Padiglione Flaiani, Roma, 00152, Italy|Centro C.O.E.S., A.O. San Giovanni Battista Le Molinette, Torino, 10126, Italy|Aichi cancer center central hospital, Nagoya, Aichi, 464-8681, Japan|National Hospital Organization Hokkaido Cancer Center, Sapporo, Hokkaido, 003-0804, Japan|Hyogo Cancer Center, Akashi, Hyogo, 673-8558, Japan|Kinki University Hospital, Osakasayama-shi, Osaka, 589-8511, Japan|Shizuoka Cancer Center, Sunto-gun, Shizuoka, 411-8777, Japan|National Cancer Center Hospital, Chuo-ku, Tokyo, 104-0045, Japan|National Kyushu Cancer Center/Department of Thoracic Oncology, Fukuoka, 811-1395, Japan|National Cancer Center Hospital East, Kashiwa, 277-8577, Japan|Okayama University Hospital, Okayama, 700-8558, Japan|The Cancer Institute Hospital of JFCR, Tokyo, 135-8550, Japan|National Cancer Center, Center for Lung Cancer, Gyeonggi-do, 410-769, Korea, Republic of|Seoul National University Hospital / Department of Internal Medicine, Seoul, 110-744, Korea, Republic of|Samsung Medical Center, Sungkyunkwan Univ School of Medicine, Seoul, 135-710, Korea, Republic of|Universitair Medisch Centrum Groningen, Groningen, 9713 GZ, Netherlands|Uniwersyteckie Centrum Kliniczne, Gdansk, 80-952, Poland|Pracownia Optyczna Bozena Lawrynowicz Optyk Dyplomowany, Olsztyn, 10-344, Poland|Ars Medica, Olsztyn, 10-357, Poland|Samodzielny Publiczny Zespol Gruzlicy i Chorob Pluc, Olsztyn, 10-357, Poland|Wojewodzki Szpital Specjalistyczny w Olsztynie, Zaklad Medycyny Nuklearnej, Olsztyn, 10-561, Poland|Oddzial Onkologii Klinicznej z Pododdzialem Dziennej Chemioterapii, Poznan, 60-569, Poland|Zaklad Diagnostyki Obrazowej, Poznan, 60-569, Poland|Republican Clinical Oncology Dispensary of the Ministry of Health of Tatarstan Republic, Kazan, 420029, Russian Federation|State Institution "National Cancer Research Center named after N.N. Blokhin' RAMS", Moscow, 115478, Russian Federation|Saint-Petersburg State Medical University named after I.P.Pavlov of Roszdrav, Saint-Petersburg, 197022, Russian Federation|Research Institute of Pulmonology, Saint-Petersburg, 197089, Russian Federation|City Clinical Oncology Dispensary, Saint-Petersburg, 198255, Russian Federation|City Clinical Oncology Dispensary, St. Petersburg, 197022, Russian Federation|Hospital Universitario Central de Asturias, Oviedo, Asturias, 33006, Spain|Hospital Universitari Germans Trias I Pujol, Badalona, Barcelona, 08916, Spain|Institut Catala D'Oncologia - Hospital Duran I Reynals, L'hospitalet de Llobregat, Barcelona, 08907, Spain|Consorcio Hospitalario Parc Tauli, Sabadell, Barcelona, 08208, Spain|Complexo Hospitalario Universitario A Coru?a, A Coru?a, Galicia, 15006, Spain|Hospital Del Mar, Barcelona, 08003, Spain|Hospital General Universitari Vall D′Hebron, Barcelona, 08035, Spain|Hospital Universitario La Paz, Madrid, 28046, Spain|Hospital de Navarra, Pamplona, 31008, Spain|Hospital Universitario Marques de Valdecilla, Santander, 39008, Spain|Hospital Universitario Virgen Del Rocio, Sevilla, 41013, Spain|Karolinska Universitetssjukhuset, Onkologiska kliniken, Stockholm, 171 76, Sweden|National Cheng Kung University Hospital, Tainan, 704, Taiwan|National Taiwan University Hospital, Department of Internal Medicine, Taipei, 100, Taiwan|Taipei Veterans General Hospital, Chest Department, Taipei, 112, Taiwan|Cancer and Haematology Centre,, Headington, Oxford, OX3 7LJ, United Kingdom|Royal Marsden Hospital, Sutton, Surrey, SM2 5PT, United Kingdom|Nuffield Health Wessex Hospital, Eastleigh, SO53 2DW, United Kingdom|Department of Oncology, London, NW3 2QG, United Kingdom|Kings College London at Guy's Hospital, London, SE1 9RT, United Kingdom|Royal Marsden Hospital, London, SW3 6JJ, United Kingdom|Christie Hospital NHS Trust, Department of Medical Oncology, Manchester, M20 4BX, United Kingdom|Somers Cancer Research Building, M824, Southampton, SO16 6YD, United Kingdom Less <<
    NCT03439215 Carcinoma, Non-Small-Cell Lung Phase 2 Recruiting June 2020 Italy ... More >> IRCCS - Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST)- Oncologia Medica Active, not recruiting Meldola, Forlì- Cesena, Italy, 47014 Sacro Cuore- Don Calabria Hospital- U.O.C. Oncologia Medica Active, not recruiting Negrar, Verona, Italy, 37024 Istituto Toscano Tumori Ospedale San Donato- U.O.C. di Oncologia Medica Dipartimento di Oncologia USL-8 Not yet recruiting Arezzo, Italy, 52100 Contact: Sergio Bracarda ?? +39 0575255438 ?? sergio.bracarda@usl8.toscana.it ?? Azienda Ospedaliera di Rilievo Nazionale "S.G. Moscati" Active, not recruiting Avellino, Italy, 83100 IRCCS Istituto Tumori Giovanni Paolo II Not yet recruiting Bari, Italy, 70124 Contact: Domenico Galetta ?? 0805555418 ?? galetta@oncologico.bari.it ?? IRCCS A.O.U. San Martino- IST- Istituto Nazionale per la Ricerca sul Cancro- U.O.S. Tumori Polmonari Not yet recruiting Genova, Italy, 16132 Contact: Francesco Grossi ?? +39 0105600385 ?? fg1965@libero.it ?? Istituto Europeo di Oncologia - Divisione di Oncologia Toracica Recruiting Milano, Italy, 20141 Contact: Filippo De Marinis, MD ?? +39 0257489482 ?? Filippo.DeMarinis@ieo.it ?? A.O.U. Policlinico di Modena- Oncologia Ematologia e Malattie Apparato Respiratorio Active, not recruiting Modena, Italy, 41124 A.O. San Gerardo Active, not recruiting Monza, Italy, 20900 Istituto Nazionale Tumori IRCCS Fondazione Pascale Not yet recruiting Napoli, Italy, 80131 Contact: Alessandro Morabito ?? 0815903631 ?? a.morabito@istitutotumori.na.it ?? Istituto Oncologico Veneto IRCCS- UOS Oncologia Toracica UOC. Oncologia Medica 2 Not yet recruiting Padova, Italy, 35128 Contact: Giulia Pasello ?? +390498215608 ?? giulia.pasello@ioveneto.it ?? Casa di Cura La Maddalena- U.O. Oncologia medica Active, not recruiting Palermo, Italy, 90146 Azienda Ospedaliera Universitaria di Parma- Struttura Complessa di Oncologia Medica Active, not recruiting Parma, Italy, 43126 Azienda Ospedaliera di Perugia- S.C. Oncologia Medica Recruiting Perugia, Italy, 06132 Contact: Rita Chiari ?? 0755784099 ?? rritachiar@gmail.com ?? Ospedale di Ravenna- Oncologia Medica Recruiting Ravenna, Italy, 48121 Contact: Federico Cappuzzo ?? +39 0544285247 ?? f.cappuzzo@googlemail.com ?? Ospedale "Infermi" Rimini Active, not recruiting Rimini, Italy, 47900 ASST della Valle Olona - Ospedale di Saronno Active, not recruiting Saronno, Italy, 21047 A.O.U. San Luigi Gonzaga Active, not recruiting Torino, Italy, 10043 Azienda ULSS 9 TREVISO-UOC Oncologia Medica Not yet recruiting Treviso, Italy, 31100 Contact: Adolfo Favaretto ?? 0422 322071 ?? agfavaretto@gmail.com ?? Policlinico 'G.B.Rossi' Borgo Roma - A.O.U. Integrata (Giampaolo Tortora)- Oncologia Medica Active, not recruiting Verona, Italy, 37134 Less <<
    NCT00965731 - Completed - -
    NCT01149785 Healthy Phase 1 Completed - United States, Florida ... More >> Pfizer Investigational Site South Miami, Florida, United States, 33143 Less <<
    NCT02727335 - Completed - -
    NCT00932451 Carcinoma, Non-Small-Cell Lung PHASE2 COMPLETED 2025-12-15 University of Alabama at Birmi... More >>ngham, Birmingham, Alabama, 35233, United States|University of Alabama at Birmingham, Birmingham, Alabama, 35294, United States|University of Arkansas for Medical Sciences, Little Rock, Arkansas, 72205, United States|Comprehensive Blood and Cancer Center, Bakersfield, California, 93309, United States|Tower Cancer Research Foundation, Beverly Hills, California, 90211-1850, United States|Tower Hematology Oncology Medical Group, Beverly Hills, California, 90211-1850, United States|Moores UCSD Cancer Center, La Jolla, California, 92037, United States|UCSD Medical Center - La Jolla, La Jolla, California, 92093-0698, United States|Drug Shipping Address: Ronald Reagen University of California-Los Angeles, Los Angeles, California, 90095-6984, United States|Ronald Reagen University of California-Los Angeles Medical Center, Los Angeles, California, 90095, United States|UCLA Opthalmic Oncology Center, Los Angeles, California, 90095, United States|University of California-Los Angeles, Los Angeles, California, 90095, United States|University of California, Irvine-Medical Center, Orange, California, 92868-3298, United States|University of California, Irvine-Pharmacy, Orange, California, 92868-3298, United States|Stanford University-Cancer Center, Palo Alto, California, 94305, United States|UC Davis Cancer Center, Sacramento, California, 95817, United States|University of California Davis Medical Center, Sacramento, California, 95817, United States|UCSD Medical Center - Hillcrest, San Diego, California, 92103, United States|Santa Monica-UCLA Medical Center & Orthopaedic Hospital Clinical Laboratory, Santa Monica, California, 90404, United States|UCLA Hematology Oncology-Santa Monica, Santa Monica, California, 90404, United States|University of California-Los Angeles, Santa Monica, California, 90404, United States|Redwood Regional Medical Group Inc, Santa Rosa, California, 95403, United States|DRUG SHIPMENT: University of Colorado Cancer Center, Aurora, Colorado, 80045, United States|Rocky Mountain Lions Eye Institute, Aurora, Colorado, 80045, United States|University of Colorado Hospital, Aurora, Colorado, 80045, United States|Kaiser Permanente Colorado - Franklin, Denver, Colorado, 80205, United States|Kaiser Permanente Colorado - Rock Creek, Lafayette, Colorado, 80026, United States|Smilow Cancer Center at Yale New Haven, Oncology Pharmacy, New Haven, Connecticut, 06510, United States|Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut, 06510, United States|Yale University, New Haven, Connecticut, 06520, United States|Michael and Dianne Bienes Cancer Center, Holy Cross Hospital, Fort Lauderdale, Florida, 33308, United States|Memorial Cancer Institute, Hollywood, Florida, 33021, United States|Cancer Center of South Florida Foundation, Inc., Lake Worth, Florida, 33461, United States|Memorial Cancer Center (West), Pembroke Pines, Florida, 33028, United States|H Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, 33612, United States|Emory University Hospital Midtown, Atlanta, Georgia, 30308, United States|Emory Clinic, Atlanta, Georgia, 30322, United States|Emory University Clinic, Atlanta, Georgia, 30322, United States|Emory University Hospital, Atlanta, Georgia, 30322, United States|Winship Cancer Institution, Atlanta, Georgia, 30322, United States|Georgia Cancer Specialists - Administrative Annex, Atlanta, Georgia, 30341, United States|MCG Health Cancer Center Pharmacy, Augusta, Georgia, 30912, United States|MCG Health System Pharmacy (Drug Shipment Only), Augusta, Georgia, 30912, United States|Medical College of Georgia, Augusta, Georgia, 30912, United States|Georgia Cancer Specialists-Stemmer, Decatur, Georgia, 30033, United States|Georgia Cancer Specialists-Macon, Macon, Georgia, 31217, United States|Georgia Cancer Specialists-Kennestone, Marietta, Georgia, 30060, United States|Georgia Cancer Specialists-Northside, Sandy Springs, Georgia, 30342, United States|OnCare Hawaii, Inc., Honolulu, Hawaii, 96813, United States|University of Hawaii - Cancer Research Center of Hawaii, Honolulu, Hawaii, 96813, United States|Hawaii Medical Center East, Honolulu, Hawaii, 96817, United States|Rush University Medical Center, Chicago, Illinois, 60612, United States|University of Chicago Medical Center (Attn: J Pi PharmD / A. Patel Pharm D), Chicago, Illinois, 60637, United States|University of Chicago Medical Center, Chicago, Illinois, 60637, United States|Ingalls Memorial Hospital (Drug Shipment Only), Harvey, Illinois, 60426, United States|Ingalls Memorial Hospital, Harvey, Illinois, 60426, United States|Monroe Medical Associates, Harvey, Illinois, 60426, United States|Monroe Medical Associates, Tinley Park, Illinois, 60477, United States|Indiana University Hospital Clarian Health, Indianapolis, Indiana, 46202, United States|Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, 46202, United States|Ship drug to: Investigational Drug Services, Indianapolis, Indiana, 46202, United States|Wishard Memorial Hospital, Indianapolis, Indiana, 46202, United States|Springmill Medical Clinic, Indianopolis, Indiana, 46290, United States|Monroe Medical Associates, Munster, Indiana, 46321, United States|The Community Hospital, Munster, Indiana, 46321, United States|Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, 21231, United States|The Harry and Jeanette Cancer Research Building, Baltimore, Maryland, 21231, United States|National Institutes of Health National Cancer Institute, Bethesda, Maryland, 20892, United States|Massachusette General Hospital, Boston, Massachusetts, 02114, United States|Massachussetts General Hospital, Boston, Massachusetts, 02114, United States|Beth Isreal Deaconess Medical Center, Pharmacy FD B18, Boston, Massachusetts, 02115, United States|Brigham and Women's Hospital, Boston, Massachusetts, 02115, United States|Beth Isreal Deaconess Medical Center, Boston, Massachusetts, 02215, United States|Dana Farber Cancer Institute/Pharmacy, Boston, Massachusetts, 02215, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Karmanos Cancer Institute, Detroit, Michigan, 48201, United States|Karmanos Cancer lnstitute at Farmington Hllls, Farmington Hills, Michigan, 48334, United States|Barnes-Jewish Hospital, St. Louis, Missouri, 63110-1094, United States|Washington University School of Medicine, St. Louis, Missouri, 63110, United States|Siteman Cancer Center, St. Peters, Missouri, 63376, United States|University of Nebraska Medical Center, Omaha, Nebraska, 68198-7680, United States|Dartmouth Hitchcock Medical Center/Mary Hitchcock Memorial Hospital, Lebanon, New Hampshire, 03756-0001, United States|University of New Mexico Eye Clinic, Albuquerque, New Mexico, 87106, United States|University of New Mexico Cancer Center, Albuquerque, New Mexico, 87131, United States|NSLIJ Health System/Monter Cancer Center, Lake Success, New York, 11042, United States|North Shore University Hospital, Manhasset, New York, 11030, United States|Long Island Jewish Medical Center, New Hyde Park, New York, 11040, United States|Memorial Sloan-Kettering Cancer Center: Rockefeller Outpatient Pavilion, New York, New York, 10022, United States|Columbia University Medical Center, New York, New York, 10032, United States|IP Shipment: CUMC Research Pharmacy, New York, New York, 10032, United States|Memorial Sloan - Kettering Cancer Center, New York, New York, 10065, United States|Department of Medicine MSG at SUNY HSC at Syracuse, INC., d/b/a University Physicians, Oneida, New York, 13421, United States|Department of Medicine MSG at SUNY HSC at Syracuse, INC., d/b/a University Physicians, Oswego, New York, 13126, United States|SUNY Upstate Medical University, Regional Oncology Center, Syracuse, New York, 13210-2306, United States|Department of Medicine MSG at SUNY HSC at Syracuse, INC., d/b/a University Physicians, Syracuse, New York, 13210, United States|UNC Health Care, Chapel Hill, North Carolina, 27514, United States|UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599-7600, United States|Presbyterian Hospital Cancer Center, Charlotte, North Carolina, 28204, United States|Presbyterian Hospital Huntersville, Huntersville, North Carolina, 28078, United States|Southern Oncology Specialists, Huntersville, North Carolina, 28078, United States|Presbyterian Hospital Matthews, Matthews, North Carolina, 28105, United States|Cleveland Clinic, Cleveland, Ohio, 44195, United States|The Ohio State University Hospital East, Columbus, Ohio, 43205, United States|The Ohio State University Investigational Drug Services, Columbus, Ohio, 43210, United States|The Ohio State University James Cancer Hospital and Solove Research Institute, Columbus, Ohio, 43210, United States|James Care in Kenny, Columbus, Ohio, 43221, United States|Oregon Health and Science University, Portland, Oregon, 97239, United States|Penn State Milton S. Hershey Medical Center, Penn State Hershey Cancer Institute, Hershey, Pennsylvania, 17033-0850, United States|Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States|Penn Presbyterian Medical Center, Philadelphia, Pennsylvania, 19104, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, 19111, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, 15232, United States|Vincent Armenio, MD, East Providence, Rhode Island, 02914, United States|Pharma Resource, East Providence, Rhode Island, 02915, United States|Medical University of South Carolina - Hollings Cancer Center, Charleston, South Carolina, 29425, United States|Tennessee Oncology, PLLC, Dickson, Tennessee, 37055, United States|Tennessee Oncology, PLLC, Franklin, Tennessee, 37067, United States|Tennessee Oncology, PLLC, Gallatin, Tennessee, 37066, United States|Tennessee Oncology, PLLC, Hermitage, Tennessee, 37076, United States|Tennessee Oncology, PLLC, Lebanon, Tennessee, 37087, United States|Tennessee Oncology, PLLC, Murfreesboro, Tennessee, 37130, United States|Sarah Cannon Research Institute (Administration), Nashville, Tennessee, 37203, United States|Sarah Cannon Research Institute (Pharmacy), Nashville, Tennessee, 37203, United States|Tennessee Oncology, PLLC, Nashville, Tennessee, 37203, United States|Tennessee Oncology, PLLC, Nashville, Tennessee, 37205, United States|Tennessee Oncology, PLLC, Nashville, Tennessee, 37207, United States|Tennessee Oncology, PLLC, Nashville, Tennessee, 37211, United States|Vanderbilt Cancer Clinic, Nashville, Tennessee, 37232-5536, United States|The Vanderbilt Chemo Clinic, Nashville, Tennessee, 37232-7610, United States|Tennessee Oncology, PLLC, Smyrna, Tennessee, 37167, United States|UT Southwestern Medical Center - Simmons Cancer Center Pharmacy, Dallas, Texas, 75390-9015, United States|University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, 75390, United States|University of Texas Southwestern University Hospital - Zale Lipshy, Dallas, Texas, 75390, United States|UT Southwestern University Hospital - William P. Clements, Jr, Dallas, Texas, 75390, United States|The University of Texas, Houston, Texas, 77030, United States|Swedish Cancer Institute, Seattle, Washington, 98104, United States|Seattle Cancer Care Alliance, Seattle, Washington, 98109, United States|Lisa Nakatsu, RPh (Drug Shipment Address), Seattle, Washington, 98122, United States|Swedish Medical Center, Seattle, Washington, 98122, United States|University of Washington Medical Center, Seattle, Washington, 98195, United States|Chris O'Brien Lifehouse, Camperdown, New South Wales, 2050, Australia|Royal Adelaide Hospital, Department of Medical Oncology, Adelaide, South Australia, 5000, Australia|Peter MacCallum Cancer Centre, Division of Haematology and Medical Oncology, East Melbourne, Victoria, 3002, Australia|Department of Medical Oncology, Nedlands, Western Australia, 6009, Australia|Nucleo de Oncologia da Bahia, Salvador, Bahia, 40170-110, Brazil|Instituto Nacional do Cancer - INCA, Rio de Janeiro, RJ, 20231-050, Brazil|Associacao Hospital de Caridade de Ijui, Ijui, RS, 98700-000, Brazil|Irmandade da Santa Casa de Misericordia de Porto Alegre, Porto Alegre, RS, 90050-170, Brazil|Hospital Sao Lucas da PUCRS, Porto Alegre, RS, 90610-000, Brazil|Fundacao Hospital Amaral Carvalho, Jau, Sao Paulo, 17210-120, Brazil|Fundacao Pio XII Hospital de Cancer de Barretos, Barretos, SP, 14784-400, Brazil|Instituto do Cancer do Estado de S?o Paulo Octavio Frias de Oliveira - ICESP, Sao Paulo, SP, 01246-000, Brazil|Fundacao Antonio Prudente, Sao Paulo, SP, 01509-900, Brazil|UMHAT Tsaritsa Yoanna - ISUL, Sofia, 1527, Bulgaria|MBAL Voennomeditsinska Academia, MMA HAT Sofia, Sofia, 1606, Bulgaria|Spetsializirana Bolnitsa za Aktivno Lechenie po Onkologiya, Klinika po himioterapiya, Sofia, 1756, Bulgaria|MDOZS "Dr. Marko Markov", Otdelenie po onkoterapiya i paliativni grizhi, Varna, 9002, Bulgaria|Tom Baker Cancer Centre, Calgary, Alberta, T2N 4N2, Canada|Alberta Health Services, Holy Cross Site, Calgary, Alberta, T2S 3C3, Canada|Office of Dr. John McWhae, Calgary, Alberta, T2V 2C4, Canada|Cross Cancer Institute, Edmonton, Alberta, T6G 1Z2, Canada|Dr. Georges-L. Dumont Regional Hospital, Moncton, New Brunswick, E1C 2Z3, Canada|Dr. Leon Richard Oncology Centre, Moncton, New Brunswick, E1C 8X3, Canada|RSM Durham Regional Cancer Centre - Lakeridge Health Oshawa, Oshawa, Ontario, L1G 2B9, Canada|Dr. Dana Blakolmer and Associates, Oshawa, Ontario, L1J 8N8, Canada|The Ottawa Hospital Cancer Center, Ottawa, Ontario, K1H 8L6, Canada|Hopital Notre-Dame du Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal, Quebec, H2L 4M1, Canada|Royal Victoria Hospital, Montreal, Quebec, H3A 1A1, Canada|Montreal General Hospital, Montreal, Quebec, H3G 1A4, Canada|Jewish General Hospsital, Montreal, Quebec, H3T 1E2, Canada|St. Mary's Hospital Center, Montreal, Quebec, H3T 1M5, Canada|SUN Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, China|Nanjing Bayi Hospital, Nanjing, Jiangsu, 210002, China|Cancer Institute and Hospital Chinese Academy of Medical Sciences and PUMC, Internal 4 Department, Beijing, 100021, China|307 Hospital of PLA, Beijing, 100071, China|Guangdong General Hospital, Guangzhou, 510080, China|Shanghai Chest Hospital/Department of Pulmonary Medicine, Shanghai, 200030, China|Shanghai Chest Hospital, Shanghai, 200030, China|Zhongshan Hospital Fudan University / Respiratory Department, Shanghai, 200032, China|Shanghai Pulmonary Hospital, Shanghai, 200433, China|Centre Francois Baclesse, Caen Cedex 05, 14076, France|Centre Georges-Fran?ois Leclerc, Dijon, 21079, France|Hopital Albert Michallon, Grenoble Cedex 09, 38043, France|APHM - Hopital Nord / Service d'Oncologie Multidisciplinaire et Innovations Thérapeutiques, Marseille Cedex 20, 13915, France|Centre Antoine Lacassagne, NICE Cedex 2, 06189, France|Hopital Tenon, Paris cedex 20, 75970, France|Hospital Cochin, Paris, 75014, France|Centre Rene Gauducheau / Service d'Oncologie Medicale, St Herblain Cedex, 44805, France|Institut Gustave Roussy, Villejuif, 94805, France|Universitaetsklinikum Carl-Gustav-Carus Dresden, Dresden, 01307, Germany|Westdeutsches Tumorzentrum, Universitaetsklinikum Essen, Innere Klinik - Tumorforschung, Essen, 45122, Germany|Krankenhaus Grosshansdorf, Zentrum fuer Pneumologie und Thoraxchirurgie, Grosshansdorf, 22927, Germany|Ambulantes Krebszentrum Hamburg, Hamburg, 22527, Germany|Thoraxklinik Heidelberg gGmbH, Heidelberg, 69126, Germany|Klinikum der Universitaet zu Koeln, Klinik I fuer Innere Medizin, Koeln, 50937, Germany|Klinikum der Universitaet Muenchen, Medizinische Klink - Innenstadt, Pneumologie, Muenchen, 80336, Germany|Pius-Hospital Oldenburg, Oldenburg, 26121, Germany|HSK Dr.- Horst-Schmidt-Kliniken, Wiesbaden, 65199, Germany|University General Hospital of Heraklion/ Department of Clinical Oncology, Heraklion, Crete, 71110, Greece|General Hospital of Thessaloniki Georgios Papanikolaou, Lung Cancer Neoplasia Research Department, Exohi, Thessaloniki, 57010, Greece|General Hospital of Chest Diseases of Athens "Sotiria", Athens, 11527, Greece|Division of Respiratory and Critical Care Medicine, Department of Medicine, Queen Mary Hospital, Pokfulam, Hong Kong|Department of Clinical Oncology, Prince of Wales Hospital, Shatin, New Territories, Hong Kong|Tuen Mun Hospital, Department of Clinical Oncology, Tuen Mun, New Territories, Hong Kong|Orszagos Koranyi TBC es Pulmonologiai Intezet, VI. Bronchologia, Budapest, 1121, Hungary|Semmelweis Egyetem Pulmonologia Intezet, Budapest, 1125, Hungary|Debreceni Egyetem Orvos - es Egeszsegtudomanyi Centrum, Tudogyogyaszati Klinika, Debrecen, 4032, Hungary|Veszprem Megyei Onkormanyzat Tudogyogyintezete, Farkasgyepu, 8582, Hungary|Fejer Megyei Szent Gyorgy Korhaz, Pulmonologiai Osztaly, Szekesfehervar, 8000, Hungary|Pest Megyei Tudogyogyintezet, III. Osztaly, Torokbalint, 2045, Hungary|Aseptic Compounding Unit, Dublin, 8, Ireland|Department of Medical Oncology, Dublin, Dublin 8, Ireland|Department of Medical Oncology, Galway, Ireland|Merlin Park Imaging Centre, Galway, Ireland|Pharmacy Aseptic Services Unit, Galway, Ireland|Divisione di Oncologia Medica, Ospedale San Giuseppe Moscati, Citta' Ospedaliera, Avellino, 83100, Italy|S.C. Oncologia Medica, Firenze, 50134, Italy|Oncologia Medica A, Genova, 16132, Italy|Ospedale Versilia, Oncologia Medica, Lido di Camaiore (LU), 55043, Italy|Ospedale San Luca, Lucca, 55100, Italy|Dipartimento Oncologia Medica, UO Medicina 1Q A, Unita' Nuovi Farmaci e Terapie Innovative, Milano, 20132, Italy|Farmacia Istituto Europeo di Oncologia, Milano, 20141, Italy|Istituto Europeo di Oncologia, Milano, 20141, Italy|Ospedale Niguarda Ca' Granda Dipartimento Oncologico, SC Divisione di Oncologia Medica Falk, Milano, 20162, Italy|Nuovo Ospedale San Gerardo, Monza, 20900, Italy|Azienda Ospedaliera Universitaria San Luigi Gonzaga, Orbassano (TO), 10043, Italy|SC Oncologia Medica, Ospedale Santa Maria della Misericordia, Azienda Ospedaliera di Perugia, Perugia, 06156, Italy|Unita' Operativa Complessa di Pneumologia Oncologica I, Padiglione Flaiani, Roma, 00152, Italy|Centro C.O.E.S., A.O. San Giovanni Battista Le Molinette, Torino, 10126, Italy|Aichi cancer center central hospital, Nagoya, Aichi, 464-8681, Japan|National Hospital Organization Hokkaido Cancer Center, Sapporo, Hokkaido, 003-0804, Japan|Hyogo Cancer Center, Akashi, Hyogo, 673-8558, Japan|Kinki University Hospital, Osakasayama-shi, Osaka, 589-8511, Japan|Shizuoka Cancer Center, Sunto-gun, Shizuoka, 411-8777, Japan|National Cancer Center Hospital, Chuo-ku, Tokyo, 104-0045, Japan|National Kyushu Cancer Center/Department of Thoracic Oncology, Fukuoka, 811-1395, Japan|National Cancer Center Hospital East, Kashiwa, 277-8577, Japan|Okayama University Hospital, Okayama, 700-8558, Japan|The Cancer Institute Hospital of JFCR, Tokyo, 135-8550, Japan|National Cancer Center, Center for Lung Cancer, Gyeonggi-do, 410-769, Korea, Republic of|Seoul National University Hospital / Department of Internal Medicine, Seoul, 110-744, Korea, Republic of|Samsung Medical Center, Sungkyunkwan Univ School of Medicine, Seoul, 135-710, Korea, Republic of|Universitair Medisch Centrum Groningen, Groningen, 9713 GZ, Netherlands|Uniwersyteckie Centrum Kliniczne, Gdansk, 80-952, Poland|Pracownia Optyczna Bozena Lawrynowicz Optyk Dyplomowany, Olsztyn, 10-344, Poland|Ars Medica, Olsztyn, 10-357, Poland|Samodzielny Publiczny Zespol Gruzlicy i Chorob Pluc, Olsztyn, 10-357, Poland|Wojewodzki Szpital Specjalistyczny w Olsztynie, Zaklad Medycyny Nuklearnej, Olsztyn, 10-561, Poland|Oddzial Onkologii Klinicznej z Pododdzialem Dziennej Chemioterapii, Poznan, 60-569, Poland|Zaklad Diagnostyki Obrazowej, Poznan, 60-569, Poland|Republican Clinical Oncology Dispensary of the Ministry of Health of Tatarstan Republic, Kazan, 420029, Russian Federation|State Institution "National Cancer Research Center named after N.N. Blokhin' RAMS", Moscow, 115478, Russian Federation|Saint-Petersburg State Medical University named after I.P.Pavlov of Roszdrav, Saint-Petersburg, 197022, Russian Federation|Research Institute of Pulmonology, Saint-Petersburg, 197089, Russian Federation|City Clinical Oncology Dispensary, Saint-Petersburg, 198255, Russian Federation|City Clinical Oncology Dispensary, St. Petersburg, 197022, Russian Federation|Hospital Universitario Central de Asturias, Oviedo, Asturias, 33006, Spain|Hospital Universitari Germans Trias I Pujol, Badalona, Barcelona, 08916, Spain|Institut Catala D'Oncologia - Hospital Duran I Reynals, L'hospitalet de Llobregat, Barcelona, 08907, Spain|Consorcio Hospitalario Parc Tauli, Sabadell, Barcelona, 08208, Spain|Complexo Hospitalario Universitario A Coru?a, A Coru?a, Galicia, 15006, Spain|Hospital Del Mar, Barcelona, 08003, Spain|Hospital General Universitari Vall D′Hebron, Barcelona, 08035, Spain|Hospital Universitario La Paz, Madrid, 28046, Spain|Hospital de Navarra, Pamplona, 31008, Spain|Hospital Universitario Marques de Valdecilla, Santander, 39008, Spain|Hospital Universitario Virgen Del Rocio, Sevilla, 41013, Spain|Karolinska Universitetssjukhuset, Onkologiska kliniken, Stockholm, 171 76, Sweden|National Cheng Kung University Hospital, Tainan, 704, Taiwan|National Taiwan University Hospital, Department of Internal Medicine, Taipei, 100, Taiwan|Taipei Veterans General Hospital, Chest Department, Taipei, 112, Taiwan|Cancer and Haematology Centre,, Headington, Oxford, OX3 7LJ, United Kingdom|Royal Marsden Hospital, Sutton, Surrey, SM2 5PT, United Kingdom|Nuffield Health Wessex Hospital, Eastleigh, SO53 2DW, United Kingdom|Department of Oncology, London, NW3 2QG, United Kingdom|Kings College London at Guy's Hospital, London, SE1 9RT, United Kingdom|Royal Marsden Hospital, London, SW3 6JJ, United Kingdom|Christie Hospital NHS Trust, Department of Medical Oncology, Manchester, M20 4BX, United Kingdom|Somers Cancer Research Building, M824, Southampton, SO16 6YD, United Kingdom Less <<
    NCT01147055 Healthy Phase 1 Completed - United States, Florida ... More >> Pfizer Investigational Site South Miami, Florida, United States, 33143 Less <<
    NCT01998126 Non-small Cell Lung Cancer Phase 1 Completed - United States, Utah ... More >> Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Less <<
    NCT03085186 Inflammatory Myofibroblastic T... More >>umour Less << NO_LONGER_AVAILABLE - -
    NCT01149785 - Completed - -
    NCT01082380 Healthy Volunteer PHASE1 COMPLETED 2025-04-10 Pfizer Investigational Site, N... More >>ew Haven, Connecticut, 06511, United States Less <<
    NCT01639001 NSCLC (Non-small Cell Lung Can... More >>cer) Less << Phase 3 Active, not recruiting January 2019 -
    NCT01082380 Healthy Volunteer PHASE1 COMPLETED 2025-04-10 Pfizer Investigational Site, N... More >>ew Haven, Connecticut, 06511, United States Less <<
    NCT01531361 Advanced Malignant Neoplasm ... More >> BRAF Gene Mutation Metastatic Malignant Neoplasm Recurrent Malignant Neoplasm Refractory Malignant Neoplasm Less << Phase 1 Active, not recruiting February 28, 2020 United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
    NCT01606878 Recurrent Childhood Anaplastic... More >> Large Cell Lymphoma Recurrent Neuroblastoma Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 1 Active, not recruiting - -
    NCT01639001 - Active, not recruiting - -
    NCT01597258 - Completed - -
    NCT01147055 - Completed - -
    NCT01576406 Advanced Cancer Phase 1 Completed - United States, California ... More >> Keck Hospital of USC Los Angeles, California, United States, 90033 LAC&USC Medical Center Los Angeles, California, United States, 90033 USC/Norris Comprehensive Cancer Center / Investigational Drug Services Los Angeles, California, United States, 90033 USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 United States, Colorado Anschutz Cancer Pavilion, Room 2224, c/o Melinda Friesleben, Pharm D Aurora, Colorado, United States, 80045 University of Colorado Denver - Clinical Translational Research Center Aurora, Colorado, United States, 80045 University of Colorado Denver, Anschutz Cancer Pavilion Aurora, Colorado, United States, 80045 University of Colorado Denver, Anschutz Inpatient Pavillion Aurora, Colorado, United States, 80045 United States, Georgia Emory University Hospital Midtown Laboratory Atlanta, Georgia, United States, 30308 Emory University Hospital Atlanta, Georgia, United States, 30322 Investigational Drug Service: The Emory Clinic Bldg A Atlanta, Georgia, United States, 30322 The Emory Clinic Atlanta, Georgia, United States, 30322 Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Ohio University Hospital East Columbus, Ohio, United States, 43205 Investigational Drug Services Columbus, Ohio, United States, 43210 James Cancer Hospital Columbus, Ohio, United States, 43210 The Ohio State University, Wexner Medical Center Columbus, Ohio, United States, 43210 Martha Morehouse Medical Plaza Columbus, Ohio, United States, 43221 United States, Texas Cancer Therapy & Research Center at UTHSCSA San Antonio, Texas, United States, 78229 Medical Arts and Research Center-MARC San Antonio, Texas, United States, 78229 Less <<
    NCT03137134 Healthy Phase 1 Completed - United States, Connecticut ... More >> Pfizer New Haven Clinical Research Unit New Haven, Connecticut, United States, 06511 Less <<
    NCT01154218 - Completed - -
    NCT02511184 ALK-positive Advanced NSCLC Phase 1 Terminated(Decision based on t... More >>he low enrollment mainly due to high efficacy drugs available in 1st line ALK-positive NSCLC (eg alectinib), not due to any safety concerns) Less << - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35233 University of Alabama at Birmingham, IDS Pharmacy Birmingham, Alabama, United States, 35249 University of Alabama at Birmingham Birmingham, Alabama, United States, 35249 United States, California City of Hope National Medical Center Duarte, California, United States, 91010 UC San Diego Moores Cancer Center - Investigational Drug Services La Jolla, California, United States, 92037-0845 UC San Diego Medical Center - La Jolla(Thornton Hospital) La Jolla, California, United States, 92037 University Of California / San Diego Moores Cancer Center La Jolla, California, United States, 92093 UC San Diego Medical Center - Hillcrest San Diego, California, United States, 92103 United States, Georgia Emory University Hospital Midtown Atlanta, Georgia, United States, 30308 Emory University Hospital Atlanta, Georgia, United States, 30322 The Emory Clinic Atlanta, Georgia, United States, 30322 Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, Ohio The Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, Washington Swedish Cancer Institute Seattle, Washington, United States, 98104 Swedish Investigational Drug Services Pharmacy Seattle, Washington, United States, 98104 Less <<
    NCT01576406 - Completed - -
    NCT02946359 Lung Adenocarcinoma Metastatic Phase 2 Unknown July 2018 China, Beijing ... More >> Chinese PLA General Hospital Recruiting Beijing, Beijing, China, 100853 Contact: haitao tao, PhD ?? +861066937875 ?? whatyouknow@126.com ?? PLA general hospital Recruiting BeiJing, Beijing, China, 100853 Contact: yi hu, M.D. ?? ?? 13718994934@126.com Less <<
    NCT00939770 ALK Fusion Protein Expression ... More >> ALK Gene Amplification ALK Gene Mutation ALK Positive c-MET Gene Amplification MET Gene Mutation Recurrent Childhood Anaplastic Large Cell Lymphoma Recurrent Malignant Solid Neoplasm Recurrent Neuroblastoma Refractory Anaplastic Large Cell Lymphoma Refractory Malignant Solid Neoplasm Refractory Neuroblastoma Less << Phase 1 Phase 2 Active, not recruiting - -
    NCT01154218 Healthy Phase 1 Completed - Belgium ... More >> Pfizer Investigational Site Bruxelles, Belgium, B-1070 Less <<
    NCT01168934 Healthy Phase 1 Completed - Belgium ... More >> Pfizer Investigational Site Bruxelles, Belgium, B-1070 Less <<
    NCT02201992 ALK Gene Rearrangement ... More >> ALK Gene Translocation ALK Positive Stage IB Non-Small Cell Lung Carcinoma AJCC v7 Stage II Non-Small Cell Lung Cancer AJCC v7 Stage IIA Non-Small Cell Lung Carcinoma AJCC v7 Stage IIB Non-Small Cell Lung Carcinoma AJCC v7 Stage IIIA Non-Small Cell Lung Cancer AJCC v7 Less << Phase 3 Recruiting - -
    NCT02075840 Non-Small Cell Lung Cancer Phase 3 Active, not recruiting January 21, 2020 -
    NCT02134912 Adenocarcinoma of the Lung ... More >> Large Cell Lung Cancer Recurrent Non-small Cell Lung Cancer Stage IV Non-small Cell Lung Cancer Less << Phase 2 Terminated(science has moved f... More >>orward and there is no intent to complete the study) Less << - -
    NCT01524926 Locally Advanced and/or Metast... More >>atic Anaplastic Large Cell Lymphoma Locally Advanced and/or Metastatic Inflammatory Myofibroblastic Tumor Locally Advanced and/or Metastatic Papillary Renal Cell Carcinoma Type 1 Locally Advanced and/or Metastatic Alveolar Soft Part Sarcoma Locally Advanced and/or Metastatic Clear Cell Sarcoma Locally Advanced and/or Metastatic Alveolar Rhabdomyosarcoma Less << Phase 2 Active, not recruiting December 2018 Belgium ... More >> H?pitaux Universitaires Bordet-Erasme - Institut Jules Bordet Brussels, Belgium U.Z. Gasthuisberg Leuven, Belgium France Institut Bergonie Bordeaux, France Centre Georges-Francois-Leclerc Dijon, France Centre Leon Berard Lyon, France Assistance Publique - H?pitaux de Marseille - H?pital de La Timone Marseille, France Institut Gustave Roussy Villejuif, France Germany Helios Klinikum Bad Saarow Bad Saarow-Pieskow, Germany Universitaetsklinikum Carl Gustav Carus Dresden, Germany Universitaetsklinikum - Essen Essen, Germany Medizinische Hochschule Hannover Hannover, Germany UniversitaetsMedizin Mannheim Mannheim, Germany Klinikum Grosshadern Ludwig-Maximilians Univ. Muenchen Muenchen, Germany Italy Fondazione IRCCS Istituto Nazionale dei Tumori Milano, Italy Netherlands Leiden University Medical Centre Leiden, Netherlands Radboud University Nijmegen Medical Centre Nijmegen, Netherlands Erasmus MC - Sophia kindersiekenhuis Rotterdam, Netherlands Norway Oslo University Hospital - Radiumhospitalet Oslo, Norway Poland Maria Sklodowska-Curie Memorial Cancer Centre Warsaw, Poland Slovakia National Cancer Institute Bratislava, Slovakia Slovenia The Institute Of Oncology Ljubljana, Slovenia United Kingdom St. James's University Hospital Leeds, United Kingdom University College Hospital London, United Kingdom Christie NHS Foundation Trust Manchester, United Kingdom Nottingham University Hospitals NHS Trust - City Hospital Nottingham, United Kingdom Less <<
    NCT01644773 Diffuse Intrinsic Pontine Glio... More >>ma High-grade Glioma Less << Phase 1 Active, not recruiting November 2020 United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
    NCT03707847 ALK-Positive Anaplastic Large ... More >>Cell Lymphoma Less << Phase 4 Recruiting February 1, 2021 China, Henan ... More >> Oncology Department of The First Affiliated Hospital of Zhengzhou University Recruiting Zhengzhou, Henan, China, 450052 Contact: Mingzhi Zhang, Pro,Dr ?? 13838565629 ?? mingzhi_zhang@126.com Less <<
    NCT02824094 - - - Japan ... More >> Aichi cancer center central hospital Nagoya, Aichi, Japan, 464-8681 National Cancer Center Hospital East Kashiwa, Chiba, Japan, 277-8577 Hyogo Cancer Center Akashi, Hyogo, Japan, 673-8558 The Cancer Institute Hospital of JFCR Koto-ku, Tokyo, Japan, 135-8550 Less <<
    NCT02075840 - Active, not recruiting - -
    NCT01125904 Healthy Phase 1 Completed - United States, Massachusetts ... More >> Pfizer Investigational Site Woburn, Massachusetts, United States, 01801 Less <<
    NCT01548144 Advanced Cancers Phase 1 Active, not recruiting April 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
    NCT01168934 - Completed - -
    NCT01500824 Non-Small Cell Lung Cancer PHASE2 WITHDRAWN 2025-05-16 -
    NCT03375242 - Recruiting August 30, 2021 Japan ... More >> Pfizer local country office Recruiting Tokyo, Japan Less <<
    NCT01297595 Healthy Phase 1 Completed - Belgium ... More >> Pfizer Investigational Site Bruxelles, Belgium, B-1070 Less <<
    NCT01419041 Renal Impairment Phase 1 Completed - United States, California ... More >> Pfizer Investigational Site Anaheim, California, United States, 92801 United States, Florida Pfizer Investigational Site DeLand, Florida, United States, 32720 United States, Minnesota Pfizer Investigational Site Saint Paul, Minnesota, United States, 55114 Less <<
    NCT01297595 - Completed - -
    NCT02074878 Breast Cancer Phase 1 Terminated(Poor accrual so the... More >> study was halted on May 16, 2017.) Less << - United States, Texas ... More >> Lester and Sue Smith Breast Center, Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
    NCT01579994 Advanced Lung Cancer Phase 1 Active, not recruiting April 2019 United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering at Mercy Medical Center Rockville Centre, New York, United States Memoral Sloan Kettering Cancer Center at Phelps Sleepy Hollow, New York, United States, 10591 Less <<
    NCT01121588 Neoplasms Malignant PHASE1 TERMINATED 2023-09-07 Highlands Oncology Group, Faye... More >>tteville, Arkansas, 72703, United States|Highlands Oncology Group, Rogers, Arkansas, 72758, United States|Highland Oncology Group, Springdale, Arkansas, 72762, United States|Washington University School of Medicine, Saint Louis, Missouri, 63110, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, 89169, United States|OHSU Center for Health and Healing 2, Portland, Oregon, 97239, United States|Oregon Health & Science University, Portland, Oregon, 97239, United States|Oregon Health and Science University, Portland, Oregon, 97239, United States|Greenville Health System, Institute for Translational Oncology Research, Greenville, South Carolina, 29605, United States|Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, Chaoyang District, 100021, China|SUN Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, China|Centro di Ricerca di Fase 1 ASST-Monza, Monza, 20090, Italy|PO San Gerardo, ASST Monza-U.O Ematologia, Monza, 20900, Italy|National Hospital Organization Nagoya Medical Center, Nagoya, Aichi, 460-0001, Japan|National Cancer Center Hospital, Chuo-ku, Tokyo, 104-0045, Japan|National Hospital Organization Kyushu Cancer Center, Fukuoka, 811-1395, Japan|Seoul National University Hospital, Seoul, 03080, Korea, Republic of|Samsung Medical Center, Seoul, 06351, Korea, Republic of|GBOU VPO "First Saint-Petersburg State Medical University n.a.I.P Pavlov" Ministry of Health, Saint-Petersburg, 197022, Russian Federation|Institute of Pedriatric Oncology, Hematology and Transplantation n.a R.M Gorbacheva, Saint-Petersburg, 197101, Russian Federation|National Taiwan University Hospital, Department of Internal Medicine, Taipei, 100, Taiwan Less <<
    NCT03052608 Carcinoma, Non-Small-Cell Lung Phase 3 Recruiting December 30, 2023 -
    NCT02270034 Glioblastoma Multiforme (Grade... More >> IV) of Cerebellum Less << PHASE1 COMPLETED 2020-10-26 Institut Català D'Oncologia L'... More >>Hospitalet (Ico), L'Hospitalet de Llobregat, Barcelona, 08908, Spain|Hospital Del Mar, Barcelona, 08003, Spain|Hospital Clínic de Barcelona, Barcelona, 08036, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain Less <<
    NCT01549574 Healthy Phase 1 Completed - Belgium ... More >> Pfizer Investigational Site Bruxelles, Belgium, B-1070 Less <<
    NCT02612194 Urinary Bladder Neoplasms|Uret... More >>eral Neoplasms|Urethral Neoplasms Less << PHASE2 TERMINATED 2019-11-21 Levine Cancer Institute, Charl... More >>otte, North Carolina, 28204, United States Less <<
    NCT02473497 Neoplasm NO_LONGER_AVAILABLE - Children's Hospital Colorado, ... More >>Aurora, Colorado, 80045, United States|Johns Hopkins All Children's Hospital, Saint Petersburg, Florida, 33701, United States|Children's Healthcare of Atlanta, Atlanta, Georgia, 30322, United States|Children's Healthcare of Atlanta, Atlanta, Georgia, 30342, United States|Boston Children's Hospital, Boston, Massachusetts, 02215, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States|West Chester Medical Center, Hawthorne, New York, 10532, United States|Cohen Children's Medical Center of New York, New Hyde Park, New York, 11040, United States|New York Medical College, Valhalla, New York, 10595, United States|Westchester Medical Center/Maria Fareri Children's Hospital, Valhalla, New York, 10595, United States|Children's Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania, 19104, United States|Children's Hospital of Philadelphia (Investigational Pharmacy), Philadelphia, Pennsylvania, 19104, United States|Rhode Island Hospital, Providence, Rhode Island, 02903, United States|St. Jude Children's Research Hospital, Memphis, Tennessee, 38105, United States|Children's Medical Center Dallas, Dallas, Texas, 75235, United States|Children's Hospital of Wisconsin, Milwaukee, Wisconsin, 53226, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, United States Less <<
    NCT02419287 Anaplastic Large Cell Lymphoma... More >>, ALK-Positive Less << Phase 2 Recruiting March 2020 Italy ... More >> ASST-Monza Recruiting Monza, Italy/MB, Italy, 20900 Contact: Carlo Gambacorti-Passerini, MD ?? +390392339553 ?? carlo.gambacorti@unimib.it ?? Principal Investigator: Carlo Gambacorti-Passerini, MD Less <<
    NCT01712217 Non-small Cell Lung Cancer(NSC... More >>LC) Less << Phase 1 Phase 2 Completed - -
    NCT02767804 Non-small Cell Lung Cancer Phase 3 Recruiting April 2020 -
    NCT02435108 c-MET Positive Gastric Cancer Phase 2 Completed - Korea, Republic of ... More >> Samsung Medical center Seoul, Korea, Republic of, 135-710 Less <<
    NCT02487316 Systemic Anaplastic Large-Cell... More >> Lymphoma Less << Phase 4 Withdrawn December 2017 China, Beijing ... More >> Weiping Liu Beijing, Beijing, China, 100142 Less <<
    NCT02737501 Non-small Cell Lung Cancer ... More >> Lung Cancer Advanced Malignancies Carcinoma Less << Phase 3 Active, not recruiting July 31, 2020 -
    NCT01744652 Advanced Cancers Phase 1 Active, not recruiting March 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
    NCT03672643 ALK or ROS1-positive NSCLC PHASE4 TERMINATED 2023-09-28 Fujian Province Oncology Hospi... More >>tal, Fuzhou, Fujian, 350014, China|The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510120, China|The First Affiliated Hospital of Guangzhou Medical University, Liwan District,Guangzhou, Guangdong, 510145, China|Eastern Theater General Hospital ,QinHuai District Medical Area, Nanjing, Jiangsu, 210002, China|Jilin Province Cancer Hospital, Changchun, Jilin, 130000, China|Jilin Provincial Cancer Hospital, Changchun, Jilin, 130012, China|Shanghai Chest Hospital, Shanghai, Shanghai, 200030, China|Sichuan Province Cancer Hospital/Department of Pulmonary Tumor, Chengdu, Sichuan, 610041, China|Sichuan Province Cancer Hospital, Chengdu, Sichuan, 610041, China|West China Hospital of Sichuan University, Chengdu, Sichuan, 610041, China|Department of Respiratory, The First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310003, China|The First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310003, China|Beijing Cancer Hospital, Internal Department, Beijing, 100142, China|Zhongshan Hospital Fudan University, Shanghai, 200032, China Less <<
    NCT01945021 Non Small Cell Lung Cancer|ROS... More >>1 Proto Oncogene|Crizotinib Less << PHASE2 COMPLETED 2020-01-22 The First Affiliated Hospital ... More >>of Anhui Medical University, Department of Medical Oncology, Hefei, Anhui, 230022, China|Department of Medical Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Chaoyang District, Beijing, 100021, China|The Military General Hospital of Beijing PLA / Medical Oncology Dept., Dongcheng District, Beijing, 100700, China|307 Hospital of PLA/Department of Lung Cancer, Fengtai District, Beijing, 100071, China|Beijing Cancer Hospital, Department of Thoracic Oncology, Haidian District, Beijing, 100142, China|Chinese PLA General Hospital, Haidian District, Beijing, 100853, China|Beijing Chest Hospital, Tongzhou District, Beijing, China|Respiration department,the First Affiliated Hospital of Third Military Medical University, PLA, Shapingba District, Chongqing, 400038, China|Fujian Province Oncology Hospital, Fuzhou, Fujian, 350014, China|SUN Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, China|The First Affiliated Hospital of Guangzhou Medical College, Guangzhou, Guangdong, 510120, China|Guangdong General Hospital, Guangzhou, Guangdong, China|Hunan Provincial Tumor Hospital/Division of Oncology, Changsha, Hunan, 410013, China|Department of Oncology, Jilin Provincial Cancer Hospital, Changchun, Jilin, China|The affiliated hospital of medical college Qingdao University / Medical oncology department, Qingdao, Shandong, 266101, China|Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai, Shanghai, 200030, China|Shanghai Chest Hospital/Lung cancer clinical center, Shanghai, Shanghai, 200030, China|Shanghai Pulmonary Hospital, Shanghai, Shanghai, 200433, China|Zhongshan Hospital Fudan University / Respiratory Department, Xuhui District, Shanghai, 200032, China|Oncology Department, West China Hospital of Sichuan University, Chengdu, Sichuan, 610041, China|Sichuan Province Cancer Hospital/Department of Pulmonary Tumor, Chengdu, Sichuan, 610041, China|Department of Thoracic Oncology, Tianjin Medical University Cancer Institute and Hospital, Hexi District, Tianjin, 300060, China|The First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310003, China|Sir Run Run Shaw Hospital of College of Medicine of Zhejiang University, Center for Oncology, Hangzhou, Zhejiang, 310016, China|Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China|Shizuoka Cancer Center, Sunto-gun, Shizuoka, 411-8777, Japan|Aichi Cancer Center Hospital, Aichi, Japan|National Cancer Center Hospital East, Chiba, Japan|NHO Shikoku Cancer Center, Ehime, Japan|NHO Kyushu Cancer Center, Fukuoka, Japan|Hyogo Cancer Center, Hyogo, Japan|Tohoku University Hospital, Miyagi, Japan|Kinki University Hospital, Osaka, Japan|Osaka City General Hospital, Osaka, Japan|Cancer Institute Hospital of JFCR, Tokyo, Japan|National Cancer Center Hospital, Tokyo, Japan|Asan Medical Center, Seoul, Korea, Republic of|Samsung Medical Center, Seoul, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of|Yonsei University, Severance Hospital, Seoul, Korea, Republic of|Taichung Veterans General Hospital, Taichung, Taiwan|National Cheng Kung University Hospital, Tainan, Taiwan|National Taiwan University Hospital, Taipei, Taiwan|Taipei Veterans General Hospital, Taipei, Taiwan Less <<
    NCT03646994 Non-small Cell Lung Cancer RECRUITING 2025-12-01 Hunan Cancer Hospital, Changsh... More >>a, Hunan, 410013, China Less <<
    NCT03647111 Non-small Cell Lung Cancer RECRUITING 2025-12-01 Hunan Cancer Hospital, Changsh... More >>a, Hunan, 410013, China Less <<
    NCT02207504 Castration-resistant Prostate ... More >>Cancer Less << Phase 1 Active, not recruiting December 2018 United States, Massachusetts ... More >> Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
    NCT03088930 Lung Cancer, Nonsmall Cell PHASE2 COMPLETED 2021-01-13 University of Colorado Denver,... More >> Aurora, Colorado, 80045, United States Less <<
    NCT02183870 Lung Cancer|Adenocarcinoma|NSC... More >>LC Less << PHASE2 COMPLETED 2020-02-29 Thoraxklinik Heidelberg, Heide... More >>lberg, Baden-Würtemberg, 69126, Germany|Universit?tsklinikum Frankfurt - Medizinische Klinik II, Frankfurt a.M., Hessen, 60590, Germany|LungenClinic Gro?hansdorf, Gro?hansdorf, Schleswig-Holstein, 22927, Germany|Evangelische Lungenklinik Berlin, Berlin, 13125, Germany|University of Cologne / LCGC, Cologne, 50937, Germany|Universit?tsklinikum Tübingen, Tübingen, Germany|Maria Rosaria Garcia Campelo, A Coruna, Spain|CEIC Hospital General Universitario de Alicante, Alicante, Spain|CEIC Hopsital Vall d'Hebron, Barcelona, Spain|Institut Catala D'Oncologia, Barcelona, Spain|Hospital Universitario Materno-Infantil de Canarias, Las Palmas de Gran Canaria, Spain|CEIC área 2 - Hospital Universitario de La Princesa, Madrid, Spain|CEIC área 6 - Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda, Spain|CEIC Malaga Nordeste - Hospital Regional Universitario Carlos Haya, Malaga, Spain|Hospital Son Llatzer, Palma de Mallorca, Spain|CEIC Hospital Universitario Virgen del Rocio, Sevilla, Spain|CEIC Hospital Clínico Universitario de Valencia, Valencia, Spain|Universit?tsspital Basel, Basel, Switzerland Less <<
    NCT02499614 Carcinoma, Non-Small-Cell Lung PHASE2 UNKNOWN 2025-12-18 IRCCS - Istituto Scientifico R... More >>omagnolo per lo Studio e la Cura dei Tumori (IRST)- Oncologia Medica, Meldola, Forlì- Cesena, 47014, Italy|Ospedale Versilia- Oncologia, Camaiore, Lucca, 55041, Italy|Ospedale per gli Infermi - Presidio Ospedaliero di Faenza- Unità Operativa di Oncologia Medica, Faenza, Ravenna, 48018, Italy|Ospedale Umberto I°- Unità Operativa di Oncologia, Lugo, Ravenna, 48022, Italy|A. O. "Ospedale di Circolo" di Busto Arsizio- Struttura Complessa di Oncologia Medica, Saronno, Varese, 21047, Italy|Sacro Cuore- Don Calabria Hospital- U.O.C. Oncologia Medica, Negrar, Verona, 37024, Italy|Istituto Toscano Tumori Ospedale San Donato- U.O.C. di Oncologia Medica Dipartimento di Oncologia USL-8, Arezzo, 52100, Italy|Azienda Ospedaliera di Rilievo Nazionale "S.G. Moscati"- U.O. di Oncologia Medica, Avellino, 83100, Italy|IRCCS Istituto Tumori "Giovanni Paolo II"- U.O. Oncologia Medica, Bari, 70124, Italy|A.O.U. Careggi- S.C. Oncologia Medica 1, Firenze, 50134, Italy|IRCCS A.O.U. San Martino- IST- Istituto Nazionale per la Ricerca sul Cancro- U.O.S. Tumori Polmonari, Genova, 16132, Italy|Ospedale Civile Livorno- U.O. Dipartimento di Oncologia Medica, Livorno, 57124, Italy|Ospedale Campo di Marte- U.O.C. di Oncologia Medica, Lucca, 55100, Italy|Istituto Europeo di Oncologia - Divisione di Oncologia Toracica, Milano, 20141, Italy|A.O.U. Policlinico di Modena- Oncologia Ematologia e Malattie Apparato Respiratorio, Modena, 41124, Italy|Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione Giovanni Pascale"- Oncologia Medica Dipartimento Toraco-Polmonare, Napoli, 80131, Italy|A.O.U. "Maggiore della Carità"- Dipartimento Oncologico, Novara, 28100, Italy|Istituto Oncologico Veneto IRCCS- UOS Oncologia Toracica UOC. Oncologia Medica 2, Padova, 35128, Italy|Casa di Cura La Maddalena- U.O. Oncologia medica, Palermo, 90146, Italy|Azienda Ospedaliera Universitaria di Parma- Struttura Complessa di Oncologia Medica, Parma, 43126, Italy|Ospedale Santa Maria della Misericordia - Azienda Ospedaliera di Perugia, Perugia, 06132, Italy|Azienda Ospedaliero Universitaria Pisana (AOUP)- Pneumo-Oncologia - Dipartimento Cardio-Toracico, Pisa, 56124, Italy|Ospedale di Ravenna- Oncologia Medica, Ravenna, 48121, Italy|Ospedale "Infermi" Rimini- UU.OO. Oncologia ed Ematologia, Rimini, 47900, Italy|Osp. Civile SS. Annunziata- U.O.C di Oncologia Medica, Sassari, 07100, Italy|Policlinico 'G.B.Rossi' Borgo Roma - A.O.U. Integrata (Giampaolo Tortora)- Oncologia Medica, Verona, 37134, Italy Less <<
    NCT02838420 Anaplastic Lymphoma Kinase-pos... More >>itive Non-small Cell Lung Cancer Less << Phase 3 Active, not recruiting December 6, 2019 China ... More >> Cancer Hospital Chinese Academy of Medical Sciences. Beijing, China, 100021 Beijing Cancer Hospital Beijing, China, 100142 Beijing Chest Hospital; Oncology Department Beijing, China, 101149 Jilin Cancer Hospital Changchun, China, 130012 the First Hospital of Jilin University Changchun, China, 130021 West China Hospital, Sichuan University Chengdu, China, 610041 Third Affiliated Hospital of Third Military Medical University ChongQing, China, 400042 Second Affiliated Hospital of Third Military Medical University Chongqing, China Sun Yet-sen University Cancer Center Guangzhou, China, 510060 Guangdong General Hospital Guangzhou, China, 510080 The First Affiliated Hospital of Guangzhou Medical University Guangzhou, China, 510120 The First Affiliated Hospital of College of Medicine, Zhejiang University Hangzhou, China, 310003 Zhejiang Cancer Hospital Hangzhou, China, 310022 Harbin Medical University Cancer Hospital Harbin, China, 150081 Jiangsu Cancer Hospital Nanjing, China, 210009 The Affiliated Hospital of Medical College Qingdao University Qingdao, China, 266003 Shanghai chest hospital Shanghai, China, 200030 Fudan University Shanghai Cancer Center Shanghai, China, 200032 Shanghai Pulmonary Hospital Shanghai, China, 200433 Korea, Republic of CHA Bundang Medical Center Gyeonggi-do, Korea, Republic of, 13496 Kangbuk Samsung Hospital Seoul, Korea, Republic of, 03181 Asan Medical Center Seoul, Korea, Republic of, 05505 Samsung Medical Center Seoul, Korea, Republic of, 6351 Thailand Rajavithi Hospital; Division of Medical Oncology Bangkok, Thailand, 10400 Ramathibodi Hospital; Dept of Med.-Div. of Med. Onc Bangkok, Thailand, 10400 Khon Kaen University Khon Kaen, Thailand, 40002 Songklanagarind Hospital; Department of Internal Medicine, Division of Respiratory Songkhla, Thailand, 90110 Less <<
    NCT03620643 Lobular Breast Carcinoma ... More >> Gastric Cancer Less << Phase 2 Not yet recruiting November 30, 2020 -
    NCT01945021 Non Small Cell Lung Cancer|ROS... More >>1 Proto Oncogene|Crizotinib Less << PHASE2 COMPLETED 2020-01-22 The First Affiliated Hospital ... More >>of Anhui Medical University, Department of Medical Oncology, Hefei, Anhui, 230022, China|Department of Medical Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Chaoyang District, Beijing, 100021, China|The Military General Hospital of Beijing PLA / Medical Oncology Dept., Dongcheng District, Beijing, 100700, China|307 Hospital of PLA/Department of Lung Cancer, Fengtai District, Beijing, 100071, China|Beijing Cancer Hospital, Department of Thoracic Oncology, Haidian District, Beijing, 100142, China|Chinese PLA General Hospital, Haidian District, Beijing, 100853, China|Beijing Chest Hospital, Tongzhou District, Beijing, China|Respiration department,the First Affiliated Hospital of Third Military Medical University, PLA, Shapingba District, Chongqing, 400038, China|Fujian Province Oncology Hospital, Fuzhou, Fujian, 350014, China|SUN Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, China|The First Affiliated Hospital of Guangzhou Medical College, Guangzhou, Guangdong, 510120, China|Guangdong General Hospital, Guangzhou, Guangdong, China|Hunan Provincial Tumor Hospital/Division of Oncology, Changsha, Hunan, 410013, China|Department of Oncology, Jilin Provincial Cancer Hospital, Changchun, Jilin, China|The affiliated hospital of medical college Qingdao University / Medical oncology department, Qingdao, Shandong, 266101, China|Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai, Shanghai, 200030, China|Shanghai Chest Hospital/Lung cancer clinical center, Shanghai, Shanghai, 200030, China|Shanghai Pulmonary Hospital, Shanghai, Shanghai, 200433, China|Zhongshan Hospital Fudan University / Respiratory Department, Xuhui District, Shanghai, 200032, China|Oncology Department, West China Hospital of Sichuan University, Chengdu, Sichuan, 610041, China|Sichuan Province Cancer Hospital/Department of Pulmonary Tumor, Chengdu, Sichuan, 610041, China|Department of Thoracic Oncology, Tianjin Medical University Cancer Institute and Hospital, Hexi District, Tianjin, 300060, China|The First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310003, China|Sir Run Run Shaw Hospital of College of Medicine of Zhejiang University, Center for Oncology, Hangzhou, Zhejiang, 310016, China|Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China|Shizuoka Cancer Center, Sunto-gun, Shizuoka, 411-8777, Japan|Aichi Cancer Center Hospital, Aichi, Japan|National Cancer Center Hospital East, Chiba, Japan|NHO Shikoku Cancer Center, Ehime, Japan|NHO Kyushu Cancer Center, Fukuoka, Japan|Hyogo Cancer Center, Hyogo, Japan|Tohoku University Hospital, Miyagi, Japan|Kinki University Hospital, Osaka, Japan|Osaka City General Hospital, Osaka, Japan|Cancer Institute Hospital of JFCR, Tokyo, Japan|National Cancer Center Hospital, Tokyo, Japan|Asan Medical Center, Seoul, Korea, Republic of|Samsung Medical Center, Seoul, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of|Yonsei University, Severance Hospital, Seoul, Korea, Republic of|Taichung Veterans General Hospital, Taichung, Taiwan|National Cheng Kung University Hospital, Tainan, Taiwan|National Taiwan University Hospital, Taipei, Taiwan|Taipei Veterans General Hospital, Taipei, Taiwan Less <<
    NCT02223819 Uveal Melanoma PHASE2 COMPLETED 2019-07-03 Mount Sinai Comprehensive Canc... More >>er Center, Miami Beach, Florida, 33140, United States|Columbia Univeristy Medical Center, New York, New York, 10032, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|The Ohio State University, Columbus, Ohio, 43210, United States Less <<
    NCT02034981 Hematologic Cancers|Solid Tumo... More >>rs|Metastatic Cancer Less << PHASE2 COMPLETED 2023-12-06 Gustave Roussy, Villejuif, Ile... More >> De France, 94805, France Less <<
    NCT04439266 Advanced Lymphoma|Advanced Mal... More >>ignant Solid Neoplasm|Hematopoietic and Lymphoid Cell Neoplasm|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma Less << PHASE2 ACTIVE_NOT_RECRUITING 2025-02-28 ECOG-ACRIN Cancer Research Gro... More >>up, Philadelphia, Pennsylvania, 19103, United States Less <<
    NCT04439253 Advanced Lymphoma|Advanced Mal... More >>ignant Solid Neoplasm|Hematopoietic and Lymphoid Cell Neoplasm|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma Less << PHASE2 ACTIVE_NOT_RECRUITING 2025-02-28 ECOG-ACRIN Cancer Research Gro... More >>up, Philadelphia, Pennsylvania, 19103, United States Less <<
    NCT04283669 Neurofibromatosis 2|Progressiv... More >>e Vestibular Schwannoma (VS) Less << PHASE2 ACTIVE_NOT_RECRUITING 2025-12-31 The University of Alabama at B... More >>irmingham (Site 700), Birmingham, Alabama, 35294, United States|Univ of California @ Los Angeles (Site 325), Los Angeles, California, 90027, United States|Children's National Medical Center (Site 775), Washington DC, District of Columbia, 20010, United States|Children's HealthCare of Atlanta (Site 950), Atlanta, Georgia, 30324, United States|Lurie Childrens Hospital of Chicago (Site 350), Chicago, Illinois, 60611, United States|University of Chicago (Site 850), Chicago, Illinois, 60637, United States|Indiana University (Site 400), Indianapolis, Indiana, 46202, United States|Johns Hopkins University (Site 250), Baltimore, Maryland, 21287, United States|Children's Hospital Boston (Site 725), Boston, Massachusetts, 02115, United States|Washington University - St. Louis (Site 900), St. Louis, Missouri, 63110, United States|New York University Medical Center (Site 200), New York, New York, 10016, United States|Memorial Sloan Kettering Cancer Center (Site 210), New York, New York, 10065, United States|Cincinnati Children's Hospital Medical Center (Site 800), Cincinnati, Ohio, 45229-3039, United States|Children's Hospital of Philadelphia (Site 750), Philadelphia, Pennsylvania, 19096, United States|Childrens Medical Center - Univ. of Texas SW (Site 917), Dallas, Texas, 75235, United States Less <<
    NCT04084717 Non-squamous Non-small-cell Lu... More >>ng Cancer|Stage IV Non-small Cell Lung Cancer|ROS1 Gene Rearrangement|MET Activating Mutation|MET Amplification Less << PHASE2 RECRUITING 2025-06-25 Princess Margaret Cancer Centr... More >>e, Toronto, Ontario, M5G 1Z5, Canada Less <<
    NCT05014464 Non-small Cell Lung Cancer PHASE2 RECRUITING 2027-08-08 Hunan Cancer Hospital, Changsh... More >>a, Hunan, 410013, China Less <<
    NCT03874273 Inflammatory Myofibroblastic T... More >>umor Less << PHASE2|PHASE3 UNKNOWN 2021-03-01 Dmitry Rogachev National Resea... More >>rch Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation Less <<

    Protocol

    Bio Calculators
    Preparing Stock Solutions 1mg 5mg 10mg

    1 mM

    5 mM

    10 mM

    2.22mL

    0.44mL

    0.22mL

    11.10mL

    2.22mL

    1.11mL

    22.21mL

    4.44mL

    2.22mL

    References

     

    Historical Records

    Categories